{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1206,"total_is_capped":false,"direct_labels_cover":6,"predictions_cover":1206,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"7976f2dfdd68","filters":{"topic":"PARP inhibition in cancer therapy"}},"results":[{"id":"W2897430921","doi":"10.1056/nejmoa1810858","title":"Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2839,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Ovarian cancer; Oncology; Chemotherapy; Internal medicine; Disease; PARP inhibitor; Cancer; Maintenance therapy; Gynecology; Poly ADP ribose polymerase; Polymerase; Biology; Enzyme","authors":[{"name":"Kathleen N. Moore","is_ca":false},{"name":"Nicoletta Colombo","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Byoung‐Gie Kim","is_ca":false},{"name":"Ana Oaknin","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Alla Lisyanskaya","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Alexandra Léary","is_ca":false},{"name":"Gabe S. Sonke","is_ca":false},{"name":"Charlie Gourley","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Antonio González-Martı́n","is_ca":false},{"name":"Carol Aghajanian","is_ca":false},{"name":"William H. Bradley","is_ca":false},{"name":"Cara Mathews","is_ca":false},{"name":"Joyce F. Liu","is_ca":false},{"name":"Elizabeth Lowe","is_ca":false},{"name":"Ralph Bloomfield","is_ca":false},{"name":"Paul DiSilvestro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01233339124823745,"gpt":0.2875400329087155,"spread":0.275206641660478,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007061707,0.0002501362,0.001017885,0.0001827658,0.0001850956,0.0002968526,0.0003020347,0.0003521132,0.0008945624],"category_scores_gemma":[0.001491253,0.0001608489,0.0004019103,0.0002560748,0.0002186409,0.0002694609,0.0001984126,0.0006159184,0.0001262804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002786166,"about_ca_system_score_gemma":0.0005607813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002811246,"about_ca_topic_score_gemma":0.0006402596,"domain_scores_codex":[0.9997414,0.0001234574,0.00002814636,0.00003559815,0.00004320138,0.00002835148],"domain_scores_gemma":[0.9990101,0.0003584029,0.0002900396,0.00004076201,0.00003841109,0.0002623217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3460417,0.006723715,0.2194913,0.002323983,0.001495107,0.002007678,0.0003745785,0.002370874,0.0262002,0.0002863546,0.004162297,0.3885221],"study_design_scores_gemma":[0.2341084,0.2904603,0.4374647,0.0004813688,0.001808727,0.009167729,0.0001865789,0.003141689,0.005725952,0.0006483436,0.01674468,0.00006143389],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845269,0.01372281,0.0001898358,0.0003049039,0.00007065338,0.0002369558,0.0001388869,0.00001944662,0.0007896181],"genre_scores_gemma":[0.9951501,0.003310407,0.0004996019,0.0003134015,0.0001047921,0.0002162383,0.0002176327,0.000002306767,0.0001855256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001017885,"threshold_uncertainty_score":0.003734589,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2528228811","doi":"10.1056/nejmoa1611310","title":"Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2458,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"Cilag; Genentech; PharmaMar; Medac; University College London; Clovis Oncology; Array BioPharma; USC Norris Comprehensive Cancer Center; Massachusetts Medical Society; Ohio State University; Teva Pharmaceutical Industries; Amgen; Pfizer; Myriad Genetics; AstraZeneca; Eli Lilly and Company; Mateon Therapeutics; GlaxoSmithKline","keywords":"Ovarian cancer; Platinum; Oncology; Maintenance therapy; Medicine; Internal medicine; Cancer; Chemotherapy; Chemistry; Biochemistry","authors":[{"name":"Mansoor R. Mirza","is_ca":false},{"name":"Bradley J. Monk","is_ca":false},{"name":"Jørn Herrstedt","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Sven Mahner","is_ca":false},{"name":"Andrés Redondo","is_ca":false},{"name":"Michel Fabbro","is_ca":false},{"name":"Jonathan A. Ledermann","is_ca":false},{"name":"Domenica Lorusso","is_ca":false},{"name":"Ignace Vergote","is_ca":false},{"name":"Noa Ben-Baruch","is_ca":false},{"name":"Christian Marth","is_ca":false},{"name":"Radosław Mądry","is_ca":false},{"name":"René dePont Christensen","is_ca":false},{"name":"Jonathan S. Berek","is_ca":false},{"name":"Anne Dørum","is_ca":false},{"name":"Anna V. Tinker","is_ca":true},{"name":"Andreas du Bois","is_ca":false},{"name":"Antonio González-Martı́n","is_ca":false},{"name":"Philippe Follana","is_ca":false},{"name":"Benedict B. Benigno","is_ca":false},{"name":"Per Rosenberg","is_ca":false},{"name":"Lucy Gilbert","is_ca":true},{"name":"B.J. Rimel","is_ca":false},{"name":"Joseph Buscema","is_ca":false},{"name":"John Balser","is_ca":false},{"name":"Shefali Agarwal","is_ca":false},{"name":"Ursula A. Matulonis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03768055663310116,"gpt":0.3259895611761575,"spread":0.2883090045430563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001226194,0.0002800764,0.001320036,0.0002700051,0.0001778119,0.0003352792,0.0005054737,0.0003816911,0.000959799],"category_scores_gemma":[0.001336836,0.0001332258,0.0005713214,0.0003098637,0.0002977577,0.0002810267,0.000234727,0.0008519077,0.0001252274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004111692,"about_ca_system_score_gemma":0.000494773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002481768,"about_ca_topic_score_gemma":0.0005659609,"domain_scores_codex":[0.9995762,0.0002279217,0.0000488219,0.00005806237,0.00005878984,0.00003027486],"domain_scores_gemma":[0.9992014,0.0002609901,0.000281892,0.00005754106,0.000038742,0.0001594943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3591326,0.008435618,0.05186505,0.00367909,0.002623578,0.0009449045,0.0003755007,0.003536284,0.03577262,0.000361177,0.003875473,0.5293981],"study_design_scores_gemma":[0.3648377,0.4430687,0.1525459,0.0006911313,0.002539115,0.006483486,0.0001375874,0.004231271,0.01076069,0.001161702,0.01347829,0.00006453708],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981375,0.01726104,0.000179284,0.0002431772,0.00005782209,0.0001768475,0.0001121862,0.00002274785,0.000571904],"genre_scores_gemma":[0.9941876,0.004495174,0.0003987018,0.0002450462,0.00008762192,0.0001774536,0.0002349843,0.000003645771,0.0001698595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001320036,"threshold_uncertainty_score":0.006484747,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2975141952","doi":"10.1056/nejmoa1910962","title":"Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2262,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; McGill University","funders":"Eisai; Pacira BioSciences; Mylan; Clovis Oncology; Pacira Pharmaceuticals; Karyopharm Therapeutics; F. Hoffmann-La Roche; Roche; GlaxoSmithKline; Takeda Oncology; Amgen; Pfizer; Fujirebio US; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ovarian cancer; Medicine; Oncology; Cancer; Gynecology; Internal medicine","authors":[{"name":"Antonio González-Martı́n","is_ca":false},{"name":"Bhavana Pothuri","is_ca":false},{"name":"Ignace Vergote","is_ca":false},{"name":"René dePont Christensen","is_ca":false},{"name":"Whitney A. Spannuth Graybill","is_ca":false},{"name":"Mansoor R. Mirza","is_ca":false},{"name":"Colleen McCormick","is_ca":false},{"name":"Domenica Lorusso","is_ca":false},{"name":"Paul Hoskins","is_ca":true},{"name":"Gilles Freyer","is_ca":false},{"name":"Klaus Baumann","is_ca":false},{"name":"К. Jardon","is_ca":true},{"name":"Andrés Redondo","is_ca":false},{"name":"Richard G. Moore","is_ca":false},{"name":"Christof Vulsteke","is_ca":false},{"name":"Roisin E. O’Cearbhaill","is_ca":false},{"name":"Bente Lund","is_ca":false},{"name":"Floor Backes","is_ca":false},{"name":"Pilar Barretina-Ginesta","is_ca":false},{"name":"Ashley Haggerty","is_ca":false},{"name":"María Jesús Rubio-Pérez","is_ca":false},{"name":"Mark S. Shahin","is_ca":false},{"name":"Giorgia Mangili","is_ca":false},{"name":"William H. Bradley","is_ca":false},{"name":"Ilan Bruchim","is_ca":false},{"name":"Kaiming Sun","is_ca":false},{"name":"Izabela A. Malinowska","is_ca":false},{"name":"Yong Li","is_ca":false},{"name":"Divya Gupta","is_ca":false},{"name":"Bradley J. Monk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01026469645237137,"gpt":0.2782807913748217,"spread":0.2680160949224503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00113898,0.0003082164,0.001269807,0.0002093758,0.0001863167,0.000364899,0.0003512889,0.0004287466,0.00117931],"category_scores_gemma":[0.001509262,0.0001919348,0.0007243493,0.0002833315,0.00026011,0.0002604441,0.0002609626,0.000866364,0.0001536194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000344233,"about_ca_system_score_gemma":0.000627664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002627774,"about_ca_topic_score_gemma":0.0008610906,"domain_scores_codex":[0.9994987,0.0002749071,0.00004182446,0.00007487283,0.00006907805,0.00004057966],"domain_scores_gemma":[0.9989797,0.0003658697,0.0003355402,0.00004609647,0.00004576122,0.0002269216],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5091743,0.007413661,0.17917,0.003030421,0.00266639,0.001276986,0.0002257858,0.002638895,0.01913593,0.000289531,0.003765951,0.2712121],"study_design_scores_gemma":[0.3631995,0.2125725,0.392803,0.0003430932,0.002176027,0.007387235,0.0001573917,0.003468911,0.00505143,0.0007089557,0.01206452,0.00006738281],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861812,0.01199664,0.000158136,0.0003090789,0.0001087017,0.0003097581,0.0002077031,0.00001816271,0.000710596],"genre_scores_gemma":[0.9953288,0.00296069,0.0004056371,0.0003250312,0.000130282,0.0002583632,0.0003337511,0.000002872242,0.0002545384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001269807,"threshold_uncertainty_score":0.006023586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2737389832","doi":"10.1016/s1470-2045(17)30469-2","title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1863,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"European Society for Medical Oncology","keywords":"Olaparib; Medicine; BRCA mutation; Ovarian cancer; Internal medicine; Oncology; Placebo; PARP inhibitor; Clinical endpoint; Population; Randomized controlled trial; Cancer; Pathology","authors":[{"name":"Éric Pujade-Lauraine","is_ca":false},{"name":"Jonathan A. Ledermann","is_ca":false},{"name":"Frédèric Selle","is_ca":false},{"name":"Val Gebski","is_ca":false},{"name":"Richard T. Penson","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Jacob Korach","is_ca":false},{"name":"Tomasz Huzarski","is_ca":false},{"name":"Andrés Poveda","is_ca":false},{"name":"Sandro Pignata","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Nicoletta Colombo","is_ca":false},{"name":"Philipp Harter","is_ca":false},{"name":"Keiichi Fujiwara","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Joyce F. Liu","is_ca":false},{"name":"Elizabeth Lowe","is_ca":false},{"name":"Ralph Bloomfield","is_ca":false},{"name":"Patricia Pautier","is_ca":false},{"name":"Tomasz Byrski","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Maria Ornella Nicoletto","is_ca":false},{"name":"Fiona Nussey","is_ca":false},{"name":"Andrew R. Clamp","is_ca":false},{"name":"A. Poveda Velasco","is_ca":false},{"name":"Manuel Rodrigues","is_ca":false},{"name":"Jean‐Pierre Lotz","is_ca":false},{"name":"Diane Provencher","is_ca":false},{"name":"Aleix Prat Aparicio","is_ca":false},{"name":"Laura Vidal Boixader","is_ca":false},{"name":"Clare L. Scott","is_ca":false},{"name":"Kenji Tamura","is_ca":false},{"name":"Mayu Yunokawa","is_ca":false},{"name":"Alla Lisyanskaya","is_ca":false},{"name":"Jacques Médioni","is_ca":false},{"name":"Nicolas Pécuchet","is_ca":false},{"name":"Coraline Dubot","is_ca":false},{"name":"Thibault De La Motte Rouge","is_ca":false},{"name":"Marie‐Christine Kaminsky","is_ca":false},{"name":"B. Weber","is_ca":false},{"name":"Alain Lortholary","is_ca":false},{"name":"Christine Parkinson","is_ca":false},{"name":"Sarah Williams","is_ca":false},{"name":"Jonathan A. Cosin","is_ca":false},{"name":"James Hoffman","is_ca":false},{"name":"Marie Plante","is_ca":false},{"name":"Allan Covens","is_ca":false},{"name":"Gabe S. Sonke","is_ca":false},{"name":"Florence Joly","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Holger W. Hirte","is_ca":false},{"name":"Amnon Amit","is_ca":true},{"name":"Tjoung-Won Park-Simon","is_ca":false},{"name":"Koji Matsumoto","is_ca":false},{"name":"Sergei Tjulandin","is_ca":false},{"name":"Jae‐Hoon Kim","is_ca":false},{"name":"Laurence Gladieff","is_ca":false},{"name":"Roberto Sabbatini","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Patrick Timmins","is_ca":false},{"name":"Daniel Kredentser","is_ca":false},{"name":"Nuria Laínez Milagro","is_ca":false},{"name":"M.P. Barretina Ginesta","is_ca":false},{"name":"Ariadna Tibau Martorell","is_ca":false},{"name":"Alfonso Gómez de Liaño","is_ca":false},{"name":"Belén Ojeda González","is_ca":false},{"name":"Linda Mileshkin","is_ca":false},{"name":"Masaki Mandai","is_ca":false},{"name":"Ingrid Boere","is_ca":false},{"name":"Petronella B. Ottevanger","is_ca":false},{"name":"Joo‐Hyun Nam","is_ca":false},{"name":"Elias Abdo Filho","is_ca":false},{"name":"Salima Hamizi","is_ca":false},{"name":"Francesco Cognetti","is_ca":false},{"name":"David Warshal","is_ca":false},{"name":"Elizabeth Dickson-Michelson","is_ca":false},{"name":"Scott Kamelle","is_ca":false},{"name":"Nathalie D. McKenzie","is_ca":false},{"name":"Gustavo C. Rodriguez","is_ca":false},{"name":"Deborah K. Armstrong","is_ca":false},{"name":"Eva Chalas","is_ca":false},{"name":"Paul Celano","is_ca":false},{"name":"Kian Behbakht","is_ca":false},{"name":"Susan A. Davidson","is_ca":false},{"name":"Stephen Welch","is_ca":false},{"name":"Limor Helpman","is_ca":false},{"name":"Ami Fishman","is_ca":true},{"name":"Ilan Bruchim","is_ca":false},{"name":"Magdalena Sikorska","is_ca":false},{"name":"Anna Słowińska","is_ca":false},{"name":"Wojciech Rogowski","is_ca":false},{"name":"Mariusz Bidziński","is_ca":false},{"name":"Beata Śpiewankiewicz","is_ca":false},{"name":"César Mendiola Fernández","is_ca":false},{"name":"Martina Gropp‐Meier","is_ca":false},{"name":"Toshiaki Saito","is_ca":false},{"name":"Kazuhiro Takehara","is_ca":false},{"name":"Takayuki Enomoto","is_ca":false},{"name":"Hidemichi Watari","is_ca":false},{"name":"Chel Hun Choi","is_ca":false},{"name":"Byoung‐Gie Kim","is_ca":false},{"name":"Jae‐Weon Kim","is_ca":false},{"name":"Roberto Hegg","is_ca":false},{"name":"Ignace Vergote","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05211112076256093,"gpt":0.3733703096465478,"spread":0.3212591888839869,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001239456,0.001576358,0.003857015,0.0004692595,0.0004052796,0.001203483,0.001050745,0.002072104,0.005457962],"category_scores_gemma":[0.001461497,0.0007361307,0.001620888,0.0005165866,0.001183337,0.001447535,0.0003967291,0.003305672,0.001127722],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004913835,"about_ca_system_score_gemma":0.0006703214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006364763,"about_ca_topic_score_gemma":0.001300518,"domain_scores_codex":[0.9995677,0.000210682,0.00003058339,0.00009420187,0.00003203859,0.0000647472],"domain_scores_gemma":[0.9992898,0.000233242,0.0001350925,0.00005843966,0.00003503199,0.0002484407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9766582,0.002404445,0.0003454743,0.0007508692,0.0006095035,0.00004274384,0.00004469023,0.0002192743,0.002060042,0.00007428463,0.0007083566,0.01608212],"study_design_scores_gemma":[0.9659812,0.0317253,0.0009189216,0.00003299423,0.0002171959,0.00003794597,0.00001675386,0.0002665651,0.0002026142,0.0001147373,0.0004722469,0.00001345903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747771,0.01521659,0.0009407399,0.001065148,0.0008130848,0.002624808,0.001505517,0.000298187,0.002758751],"genre_scores_gemma":[0.9829664,0.006303541,0.00143255,0.00148421,0.0005121696,0.002032467,0.001457764,0.00004359632,0.003767189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005457962,"threshold_uncertainty_score":0.01825869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966928113","doi":"10.1126/science.1072221","title":"Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor","year":2002,"lang":"en","type":"article","venue":"Science","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1812,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Poly ADP ribose polymerase; Apoptosis-inducing factor; Programmed cell death; Apoptosis; Mitochondrion; Cell biology; Caspase; Biology; Molecular biology; Polymerase; Chemistry; Biochemistry; DNA","authors":[{"name":"Seong-Woon Yu","is_ca":false},{"name":"Hongmin Wang","is_ca":false},{"name":"Marc F. Poitras","is_ca":false},{"name":"Carmen Coombs","is_ca":false},{"name":"William J. Bowers","is_ca":false},{"name":"Howard J. Federoff","is_ca":false},{"name":"Guy G. Poirier","is_ca":true},{"name":"Ted M. Dawson","is_ca":false},{"name":"Valina L. Dawson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03233130338969271,"gpt":0.2929682653358566,"spread":0.2606369619461639,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001565154,0.0004084343,0.0002244527,0.0001490451,0.0001286771,0.0004139154,0.0002482808,0.0003653886,0.001884774],"category_scores_gemma":[0.0001988816,0.00009891314,0.0001942683,0.0001022569,0.0003355302,0.0003596034,0.0001602057,0.0007932637,0.0004798504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000284397,"about_ca_system_score_gemma":0.0001718071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001192016,"about_ca_topic_score_gemma":0.0001672973,"domain_scores_codex":[0.9998516,0.00003297713,0.00001078213,0.00002756173,0.0000337703,0.00004334622],"domain_scores_gemma":[0.9998901,0.00002857128,0.00003452546,0.00001734327,0.00001077673,0.00001871092],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003629426,0.0001132062,0.0001768204,0.0001274254,0.000009379194,0.0002098739,0.00002287926,0.0001249602,0.9918284,0.0009386041,0.0001766099,0.005908831],"study_design_scores_gemma":[0.00004939892,0.0004839029,0.001213636,0.000006127679,0.000009258149,0.0003027061,0.00001361925,0.0006105782,0.9941072,0.0002482209,0.002952437,0.000002813462],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9554501,0.01889573,0.01616129,0.0008347665,0.0002539192,0.00008670233,0.000415113,0.0002653023,0.007637136],"genre_scores_gemma":[0.9895057,0.004977063,0.002676873,0.00008049013,0.00003561272,0.00004854257,0.0003583972,0.000009039616,0.002308182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001884774,"threshold_uncertainty_score":0.006305218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2754327139","doi":"10.1016/s0140-6736(17)32440-6","title":"Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1704,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"Janssen Biotech; National Cancer Institute; Stand Up To Cancer; EMD Serono; Genentech; ImmunoGen; Ajinomoto; Clovis Oncology; Amgen; American Association for Cancer Research; National Ovarian Cancer Coalition; Regeneron Pharmaceuticals; University College London; Cancer Research UK; Array BioPharma; Memorial Sloan-Kettering Cancer Center; Ajinomoto Pharmaceuticals; Roche; AbbVie; Merck; Ovarian Cancer Research Fund; AstraZeneca; OncoMed Pharmaceutical; Ovarian Cancer Research Fund Alliance; U.S. Department of Defense","keywords":"Medicine; Placebo; Oncology; Internal medicine; Ovarian carcinoma; Double blind; Ovarian cancer; Surgery; Cancer; Alternative medicine; Pathology","authors":[{"name":"Robert L. Coleman","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Domenica Lorusso","is_ca":false},{"name":"Carol Aghajanian","is_ca":false},{"name":"Ana Oaknin","is_ca":false},{"name":"Andrew Dean","is_ca":false},{"name":"Nicoletta Colombo","is_ca":false},{"name":"Johanne I. Weberpals","is_ca":true},{"name":"Andrew R. Clamp","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Alexandra Léary","is_ca":false},{"name":"Robert W. Holloway","is_ca":false},{"name":"Margarita Amenedo","is_ca":false},{"name":"Peter C.C. Fong","is_ca":false},{"name":"Jeffrey C. Goh","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Deborah K. Armstrong","is_ca":false},{"name":"Jesús García-Donás","is_ca":false},{"name":"Elizabeth M. Swisher","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Gottfried E. Konecny","is_ca":false},{"name":"Iain A. McNeish","is_ca":false},{"name":"Clare L. Scott","is_ca":false},{"name":"T. Cameron","is_ca":false},{"name":"Lara Maloney","is_ca":false},{"name":"Jeff Isaacson","is_ca":false},{"name":"Sandra Goble","is_ca":false},{"name":"Caroline A. Grace","is_ca":false},{"name":"Thomas C. Harding","is_ca":false},{"name":"Mitch Raponi","is_ca":false},{"name":"James Sun","is_ca":false},{"name":"Kevin Lin","is_ca":false},{"name":"Heidi Giordano","is_ca":false},{"name":"Jonathan A. Ledermann","is_ca":false},{"name":"Martin Buck","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Paul R. Harnett","is_ca":false},{"name":"Ganessan Kichenadasse","is_ca":false},{"name":"Hannelore Denys","is_ca":false},{"name":"Luc Dirix","is_ca":false},{"name":"Ignace Vergote","is_ca":false},{"name":"Laurie Elit","is_ca":false},{"name":"Prafull Ghatage","is_ca":false},{"name":"Marie Plante","is_ca":false},{"name":"Diane Provencher","is_ca":false},{"name":"Stephen Welch","is_ca":false},{"name":"Laurence Gladieff","is_ca":false},{"name":"Florence Joly","is_ca":false},{"name":"Alain Lortholary","is_ca":false},{"name":"Jean‐Pierre Lotz","is_ca":false},{"name":"Jacques Médioni","is_ca":false},{"name":"Olivier Trédan","is_ca":false},{"name":"Benoît You","is_ca":false},{"name":"Ayşe Balat","is_ca":false},{"name":"Claudia Hänle","is_ca":false},{"name":"Petra Krabisch","is_ca":false},{"name":"Tanja Neunhöffer","is_ca":false},{"name":"Martin Pölcher","is_ca":false},{"name":"Pauline Wimberger","is_ca":false},{"name":"Svetlana Kovel","is_ca":false},{"name":"Michelle Leviov","is_ca":false},{"name":"Tamar Safra","is_ca":false},{"name":"Ronnie Shapira‐Frommer","is_ca":false},{"name":"Salomon M. Stemmer","is_ca":false},{"name":"Alessandra Bologna","is_ca":false},{"name":"Sandro Pignata","is_ca":false},{"name":"Roberto Sabbatini","is_ca":false},{"name":"Stefano Tamberi","is_ca":false},{"name":"Claudio Zamagni","is_ca":false},{"name":"Anne O’Donnell","is_ca":false},{"name":"A. Casado Herráez","is_ca":false},{"name":"E.M. Guerra","is_ca":false},{"name":"Isabel Palacio","is_ca":false},{"name":"Ignacio Romero","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Yvette Drew","is_ca":false},{"name":"Hani Gabra","is_ca":false},{"name":"D Jackson","is_ca":false},{"name":"JA Ledermann","is_ca":false},{"name":"C. A. Parkinson","is_ca":false},{"name":"Melanie Powell","is_ca":false},{"name":"Michael J. Birrer","is_ca":false},{"name":"Mary K. Buss","is_ca":false},{"name":"Suzanne K. Chambers","is_ca":false},{"name":"LM Chen","is_ca":false},{"name":"Ling Ma","is_ca":false},{"name":"Mark A. Morgan","is_ca":false},{"name":"Ronnie Morris","is_ca":false},{"name":"David G. Mutch","is_ca":false},{"name":"Brian M. Slomovitz","is_ca":false},{"name":"Timothy J. Vanderkwaak","is_ca":false},{"name":"Michel Vulfovich","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.11880331611037,"gpt":0.3994762313502411,"spread":0.2806729152398711,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002213744,0.001521494,0.004024395,0.0004159884,0.0004644228,0.001112396,0.001168067,0.00232124,0.007533734],"category_scores_gemma":[0.001686543,0.0006683618,0.0025389,0.0005333351,0.001297955,0.001156834,0.0004201064,0.004116211,0.00141383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007199771,"about_ca_system_score_gemma":0.0009586539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001320822,"about_ca_topic_score_gemma":0.002968155,"domain_scores_codex":[0.9993331,0.0003215375,0.00003930859,0.00012781,0.00004995495,0.000128305],"domain_scores_gemma":[0.9992168,0.0002393916,0.0001642844,0.00009010776,0.000042205,0.000247304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.979787,0.001722323,0.0002867952,0.0007232729,0.001120385,0.00003500428,0.00003360192,0.0001728431,0.001628078,0.00008447716,0.0009086413,0.01349762],"study_design_scores_gemma":[0.9730214,0.02466357,0.0009040945,0.00002862088,0.0003855557,0.00003089079,0.000009713796,0.0001612104,0.0001772778,0.00008987096,0.0005157768,0.00001201522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.965858,0.01989803,0.001343279,0.001534424,0.00136152,0.003844523,0.002128333,0.0004783804,0.003553507],"genre_scores_gemma":[0.9802458,0.00586958,0.00176086,0.00201902,0.0006715829,0.003055948,0.001562067,0.00006278102,0.004752506],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007533734,"threshold_uncertainty_score":0.02520281,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3093265161","doi":"10.1016/s0140-6736(10)60892-6","title":"Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1636,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Susan G. Komen; Cancer Research Society; AstraZeneca","keywords":"Olaparib; Medicine; Tolerability; Breast cancer; Cohort; PARP inhibitor; Internal medicine; BRCA mutation; Oncology; Adverse effect; Nausea; Cancer; Poly ADP ribose polymerase; Polymerase; Biology; Genetics","authors":[{"name":"Andrew Tutt","is_ca":false},{"name":"Mark E. Robson","is_ca":false},{"name":"Judy E. Garber","is_ca":false},{"name":"Susan M. Domchek","is_ca":false},{"name":"M. William Audeh","is_ca":false},{"name":"Jeffrey N. Weitzel","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Banu Arun","is_ca":false},{"name":"Niklas Loman","is_ca":false},{"name":"Rita K. Schmutzler","is_ca":false},{"name":"Andrew Wardley","is_ca":false},{"name":"Gillian Mitchell","is_ca":false},{"name":"Helena Earl","is_ca":false},{"name":"Mark Wickens","is_ca":false},{"name":"James Carmichael","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01882420731186658,"gpt":0.3056834608736979,"spread":0.2868592535618313,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00184661,0.001856421,0.002952422,0.000344727,0.0003167197,0.001473098,0.0007711128,0.001977775,0.004449786],"category_scores_gemma":[0.001907976,0.0006280521,0.002164836,0.000450961,0.0009439848,0.00135371,0.0004043211,0.005409691,0.0008418506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009634982,"about_ca_system_score_gemma":0.001045932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007736528,"about_ca_topic_score_gemma":0.001581907,"domain_scores_codex":[0.9994687,0.0002607828,0.00002495645,0.00008664507,0.00004982117,0.0001091526],"domain_scores_gemma":[0.9991065,0.0003989649,0.0001190372,0.00005346479,0.00004659272,0.0002755847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8837184,0.005225741,0.00108139,0.001591209,0.001846767,0.0001879723,0.0001098361,0.001233841,0.004644841,0.0004055957,0.00393058,0.09602389],"study_design_scores_gemma":[0.9293479,0.06292742,0.001682092,0.0001168119,0.0008045891,0.0001593467,0.00004162353,0.0005813358,0.0006395478,0.0004770244,0.003194146,0.00002826264],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9291678,0.04714403,0.002375969,0.005323501,0.001967963,0.003358099,0.002997374,0.0002683907,0.007396844],"genre_scores_gemma":[0.96641,0.01910131,0.002457652,0.00355571,0.0006774373,0.001696926,0.001710911,0.00004670944,0.004343296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004449786,"threshold_uncertainty_score":0.01488602,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086038769","doi":"10.1038/nrc2812","title":"PARP inhibition: PARP1 and beyond","year":2010,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1311,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Université Laval","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; National Institute of General Medical Sciences; Canada Research Chairs","keywords":"Limelight; PARP1; Poly ADP ribose polymerase; Polymerase; Biology; Computational biology; Enzyme; Chemistry; Biochemistry","authors":[{"name":"Michèle Rouleau","is_ca":true},{"name":"Anand G. Patel","is_ca":false},{"name":"Michael J. Hendzel","is_ca":true},{"name":"Scott H. Kaufmann","is_ca":false},{"name":"Guy G. Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04985341091087907,"gpt":0.4307639022885119,"spread":0.3809104913776328,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007759602,0.001863029,0.002664626,0.001847888,0.0004155041,0.001574298,0.001575271,0.002099356,0.006043697],"category_scores_gemma":[0.0008254042,0.0004929547,0.0007357179,0.002395539,0.0008480658,0.002470253,0.001156695,0.005246961,0.00519629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001120011,"about_ca_system_score_gemma":0.0012288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001017126,"about_ca_topic_score_gemma":0.002515089,"domain_scores_codex":[0.9997357,0.00004414543,0.00002507736,0.00004322075,0.0001162463,0.00003578956],"domain_scores_gemma":[0.999592,0.0001640537,0.00005239017,0.00001391065,0.0001146811,0.00006300573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001921291,0.0001179549,0.00008485557,0.008467362,0.00007053126,0.0001752749,0.00003211963,0.0005251621,0.002257258,0.00387638,0.1362614,0.8479395],"study_design_scores_gemma":[0.0000543209,0.00009395033,0.0003307768,0.001803559,0.00006058686,0.0007419662,0.00003168896,0.0001145345,0.0003421958,0.002666947,0.9937388,0.00002062245],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004855331,0.9975747,0.0001476073,0.0006482736,0.000587645,0.000005732171,0.00002232571,0.00001209062,0.0009530195],"genre_scores_gemma":[0.000309167,0.997672,0.0001355414,0.0005589375,0.0003774644,0.000008238309,0.0000363599,0.000001839246,0.0009004751],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006043697,"threshold_uncertainty_score":0.02021819,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2557666746","doi":"10.1016/s1470-2045(16)30559-9","title":"Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1200,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network","funders":"Cancer Research UK; Clovis Oncology; Ovarian Cancer Research Fund; Stand Up To Cancer; Healthway; U.S. Department of Defense; National Ovarian Cancer Coalition; Ovarian Cancer Research Fund Alliance; American Association for Cancer Research","keywords":"Open label; Oncology; Medicine; Internal medicine; Ovarian carcinoma; Platinum; Ovarian cancer; Clinical trial; Cancer; Chemistry","authors":[{"name":"Elizabeth M. Swisher","is_ca":false},{"name":"Kevin Lin","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Clare L. Scott","is_ca":false},{"name":"Heidi Giordano","is_ca":false},{"name":"James Sun","is_ca":false},{"name":"Gottfried E. Konecny","is_ca":false},{"name":"Robert L. Coleman","is_ca":false},{"name":"Anna V. Tinker","is_ca":true},{"name":"David M. O’Malley","is_ca":false},{"name":"Rebecca Kristeleit","is_ca":false},{"name":"Ling Ma","is_ca":false},{"name":"Katherine M. Bell‐McGuinn","is_ca":false},{"name":"James D. Brenton","is_ca":false},{"name":"Janiel M. Cragun","is_ca":false},{"name":"Ana Oaknin","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Maria I. Harrell","is_ca":false},{"name":"Elaina Mann","is_ca":false},{"name":"Scott H. Kaufmann","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Alexandra Léary","is_ca":false},{"name":"Thomas C. Harding","is_ca":false},{"name":"Sandra Goble","is_ca":false},{"name":"Lara Maloney","is_ca":false},{"name":"Jeff Isaacson","is_ca":false},{"name":"Andrew R. Allen","is_ca":false},{"name":"Lindsey Rolfe","is_ca":false},{"name":"Roman Yelensky","is_ca":false},{"name":"Mitch Raponi","is_ca":false},{"name":"Iain A. McNeish","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1468834883678543,"gpt":0.4311228869311657,"spread":0.2842393985633114,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001909533,0.001609643,0.00255087,0.0003915906,0.0003098634,0.001237936,0.001014195,0.00162487,0.00538216],"category_scores_gemma":[0.001335877,0.0004909491,0.00176682,0.000427501,0.000804156,0.001336128,0.0004292531,0.004622358,0.001436219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008122993,"about_ca_system_score_gemma":0.0008818129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007909434,"about_ca_topic_score_gemma":0.002456791,"domain_scores_codex":[0.9995245,0.000211317,0.00001566193,0.00009241849,0.0000408014,0.0001154514],"domain_scores_gemma":[0.9993293,0.0001556494,0.0001106707,0.00007922612,0.00003442714,0.0002907613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7911469,0.02008582,0.002915731,0.00203434,0.003061134,0.0002713131,0.0002371805,0.00319819,0.01400797,0.0006323219,0.01104237,0.1513667],"study_design_scores_gemma":[0.8638442,0.1216533,0.005008267,0.00007965576,0.0007378084,0.0003404723,0.00006198061,0.001567659,0.001767188,0.0004324607,0.004457132,0.00004980301],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757085,0.0117281,0.0009870726,0.001553231,0.0004880175,0.001767965,0.00268218,0.0004064905,0.004678438],"genre_scores_gemma":[0.9743536,0.005971343,0.00223648,0.00253569,0.0004154857,0.002053814,0.005393807,0.0001087022,0.006931029],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00538216,"threshold_uncertainty_score":0.01800507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117964602","doi":"10.1016/s1470-2045(11)70214-5","title":"Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1113,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Juravinski Cancer Centre; Vancouver General Hospital; Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal; Université de Montréal; BC Cancer Agency; Princess Margaret Cancer Centre; Jewish General Hospital","funders":"AstraZeneca","keywords":"Medicine; Olaparib; Internal medicine; Tolerability; Breast cancer; Ovarian cancer; Oncology; BRCA mutation; PARP inhibitor; Clinical endpoint; Triple-negative breast cancer; Adverse effect; Response Evaluation Criteria in Solid Tumors; Cancer; Serous fluid; Phases of clinical research; Clinical trial","authors":[{"name":"Karen A. Gelmon","is_ca":true},{"name":"Marc Tischkowitz","is_ca":true},{"name":"Helen Mackay","is_ca":true},{"name":"Kenneth D. Swenerton","is_ca":true},{"name":"André Robidoux","is_ca":true},{"name":"Katia Tonkin","is_ca":false},{"name":"Hal W. Hirte","is_ca":true},{"name":"David G. Huntsman","is_ca":true},{"name":"Mark Clemons","is_ca":true},{"name":"C. Blake Gilks","is_ca":true},{"name":"Rinat Yerushalmi","is_ca":true},{"name":"Euan Macpherson","is_ca":false},{"name":"James Carmichael","is_ca":false},{"name":"Amit M. Oza","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1110609224459381,"gpt":0.3838345029660907,"spread":0.2727735805201525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001518688,0.00164626,0.003119019,0.0003678015,0.0003383737,0.001309311,0.0006725653,0.001515906,0.002947871],"category_scores_gemma":[0.002001887,0.000702781,0.002391229,0.0005405281,0.001074727,0.001339738,0.0004801437,0.002680496,0.000673212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000652259,"about_ca_system_score_gemma":0.000742389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007898663,"about_ca_topic_score_gemma":0.001385797,"domain_scores_codex":[0.9992493,0.0004014163,0.00005028744,0.0001283676,0.00005859277,0.0001120569],"domain_scores_gemma":[0.9990572,0.0003467516,0.0002043744,0.00009641634,0.00004252171,0.0002526743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.968868,0.003447413,0.002909726,0.0006636194,0.001586037,0.0001128347,0.00008157673,0.0004786997,0.00261835,0.00006752579,0.000528466,0.0186378],"study_design_scores_gemma":[0.9204349,0.06985808,0.006698267,0.00003693797,0.001100742,0.0001336994,0.00005471263,0.0004784024,0.0002872969,0.0001777412,0.0007094108,0.00002987268],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927713,0.004122259,0.0003686535,0.0004076777,0.0002114368,0.0006877633,0.0006363013,0.00004401532,0.0007503881],"genre_scores_gemma":[0.992995,0.002809852,0.0005907576,0.0007372315,0.0002237249,0.0007170221,0.0008505413,0.00001586107,0.001060071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003119019,"threshold_uncertainty_score":0.009861588,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074952360","doi":"10.1038/bjc.2012.451","title":"Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer","year":2012,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"University of California, San Francisco; University of Texas MD Anderson Cancer Center; U.S. Public Health Service; National Cancer Institute; U.S. Department of Health and Human Services; Science Foundation Ireland; Conquer Cancer Foundation; National Institutes of Health; Stand Up To Cancer; Entertainment Industry Foundation","keywords":"Loss of heterozygosity; Homologous recombination; Ovarian cancer; Biology; Homologous chromosome; Cancer research; Breast cancer; DNA repair; BRCA2 Protein; Genome instability; Cancer; Genetics; Oncology; Allele; DNA; Gene; Medicine; DNA damage; Mutation; Germline mutation","authors":[{"name":"Victor Abkevich","is_ca":false},{"name":"Kirsten M. Timms","is_ca":false},{"name":"Bryan T. Hennessy","is_ca":false},{"name":"Jennifer Potter","is_ca":false},{"name":"Mark Carey","is_ca":true},{"name":"Lisa Meyer","is_ca":false},{"name":"Karen Smith‐McCune","is_ca":false},{"name":"Russell Broaddus","is_ca":false},{"name":"K.H. Lu","is_ca":false},{"name":"J Chen","is_ca":false},{"name":"Thuan Van Tran","is_ca":false},{"name":"Deniece R. Williams","is_ca":false},{"name":"Diana Iliev","is_ca":false},{"name":"Srikanth Jammulapati","is_ca":false},{"name":"Liesel M. FitzGerald","is_ca":false},{"name":"Thomas C. Krivak","is_ca":false},{"name":"Julie A. DeLoia","is_ca":false},{"name":"Alexander Gutin","is_ca":false},{"name":"Gordon B. Mills","is_ca":true},{"name":"J. S. Lanchbury","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01701151675669156,"gpt":0.2972541560484307,"spread":0.2802426392917391,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006082515,0.0001360267,0.0002418002,0.001421392,0.0001384813,0.0004278594,0.0001914182,0.0003982167,0.001706561],"category_scores_gemma":[0.002935456,0.0001465871,0.0001652122,0.0007673191,0.0003094462,0.0001913291,0.0004333362,0.0003224697,0.0002261791],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001418485,"about_ca_system_score_gemma":0.0001091235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004742741,"about_ca_topic_score_gemma":0.0006186904,"domain_scores_codex":[0.9996697,0.00006962896,0.00005617626,0.0000705818,0.00008095925,0.00005310369],"domain_scores_gemma":[0.9967739,0.001392729,0.001211147,0.000157876,0.0002153945,0.0002488556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003315162,0.0000247832,0.984711,0.00002281455,0.00004101422,0.0001367744,0.00003863368,0.0001421614,0.01156321,0.00001802777,0.00006235109,0.002907737],"study_design_scores_gemma":[0.000006220098,0.0001078023,0.9959688,0.000002964214,0.0000274193,0.001440568,0.00006041529,0.000274008,0.001913464,0.00004186889,0.000153839,0.000002541115],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991964,0.000215967,0.0002153516,0.00001548069,0.000001218376,0.00000450122,0.0001258275,0.000007233198,0.0002181074],"genre_scores_gemma":[0.9993623,0.00007159331,0.0002358254,0.000007282071,0.000002287185,0.000004963436,0.0002629189,0.000002341955,0.00005060513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001706561,"threshold_uncertainty_score":0.005709052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951058429","doi":"10.1093/annonc/mdz192","title":"A decade of clinical development of PARP inhibitors in perspective","year":2019,"lang":"en","type":"review","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":730,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Fundación Fero; Institute of Cancer Research; Prostate Cancer Foundation; Cancer Research UK; National Institute on Handicapped Research; Department of Health and Aged Care, Australian Government; Instituto de Salud Carlos III; National Institute for Health and Care Research","keywords":"Medicine; Perspective (graphical); Intensive care medicine; Medical physics; Artificial intelligence","authors":[{"name":"Christopher J. Lord","is_ca":false},{"name":"Violeta Serra","is_ca":false},{"name":"Andrew Tutt","is_ca":false},{"name":"Judith Balmañà","is_ca":false},{"name":"Marta Castroviejo‐Bermejo","is_ca":false},{"name":"Cristina Cruz","is_ca":false},{"name":"Ana Oaknin","is_ca":false},{"name":"Stan B. Kaye","is_ca":false},{"name":"Johann S. de Bono","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5086532471183037,"gpt":0.6122749549852945,"spread":0.1036217078669908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002622392,0.001745068,0.003497271,0.003789016,0.0004082511,0.003145244,0.001563375,0.002812019,0.006395989],"category_scores_gemma":[0.00457228,0.0006801779,0.001337594,0.003571772,0.001062608,0.004925475,0.001630154,0.006029717,0.003075807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001534513,"about_ca_system_score_gemma":0.002413004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001175771,"about_ca_topic_score_gemma":0.003364268,"domain_scores_codex":[0.9992371,0.0001670903,0.0001432429,0.0001258023,0.0002283958,0.00009841091],"domain_scores_gemma":[0.9973514,0.001369801,0.0003887573,0.00006179255,0.0005767598,0.0002514723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004611623,0.0001213296,0.0001981198,0.02789472,0.000199285,0.0002613798,0.00008508424,0.0007005179,0.001299474,0.00592473,0.1204948,0.8423595],"study_design_scores_gemma":[0.0001198885,0.0003508547,0.000480149,0.008263323,0.0002737111,0.0007864109,0.00006853757,0.0001564203,0.0002491579,0.002232874,0.9869883,0.00003027665],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000524151,0.9977118,0.00008380967,0.0008752938,0.0007783016,0.000003482711,0.00002146576,0.000007904642,0.0004656053],"genre_scores_gemma":[0.0005167111,0.9952739,0.0001701678,0.002374679,0.001158897,0.000007634577,0.00004390204,0.000003187638,0.0004509629],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006395989,"threshold_uncertainty_score":0.02139676,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006806309","doi":"10.1073/pnas.0606528103","title":"Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death","year":2006,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":717,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institutes of Health; University of Ottawa; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Apoptosis-inducing factor; Poly ADP ribose polymerase; Programmed cell death; Apoptosis; Cytoplasm; Cell biology; Mitochondrion; Biology; Chemistry; Polymerase; Biochemistry; Caspase; Enzyme","authors":[{"name":"Seong-Woon Yu","is_ca":false},{"name":"Shaida A. Andrabi","is_ca":false},{"name":"Hongmin Wang","is_ca":false},{"name":"No Soo Kim","is_ca":false},{"name":"Guy G. Poirier","is_ca":true},{"name":"Ted M. Dawson","is_ca":false},{"name":"Valina L. Dawson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05769557500955475,"gpt":0.3235504315589136,"spread":0.2658548565493588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001523324,0.0002788757,0.0002231137,0.0001404675,0.000141067,0.0003139419,0.000135141,0.0002583178,0.002167322],"category_scores_gemma":[0.0001476287,0.00008958695,0.0002484543,0.00009803908,0.0001749764,0.0003220734,0.0001919456,0.000589943,0.001172028],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000248702,"about_ca_system_score_gemma":0.0001088394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008141468,"about_ca_topic_score_gemma":0.0001064184,"domain_scores_codex":[0.9998453,0.00002412298,0.000007459935,0.00002672415,0.00004858378,0.00004771284],"domain_scores_gemma":[0.9999027,0.00002052903,0.00002634909,0.00001313459,0.00001344366,0.00002376925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001598396,0.00005020471,0.0002510396,0.00004326142,0.000008590045,0.0002157741,0.00001277785,0.00006175443,0.9948112,0.0002952225,0.0001575612,0.00393285],"study_design_scores_gemma":[0.00002316246,0.0003274413,0.003892912,0.000004345307,0.00001038695,0.0006856899,0.00002343716,0.000841856,0.9901702,0.0001616953,0.003855844,0.00000312354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787513,0.004121612,0.01119369,0.0004073215,0.00009586101,0.00004104112,0.0002749676,0.0001533002,0.004960871],"genre_scores_gemma":[0.9909107,0.001941675,0.002389892,0.00008584993,0.00002894619,0.00002492687,0.0005597112,0.00001417406,0.004044098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002167322,"threshold_uncertainty_score":0.007250369,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059397580","doi":"10.1073/pnas.0606526103","title":"Poly(ADP-ribose) (PAR) polymer is a death signal","year":2006,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":636,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"National Institutes of Health; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Poly ADP ribose polymerase; Programmed cell death; Apoptosis; Excitotoxicity; Chemistry; Cell biology; Biology; Molecular biology; Biochemistry; Polymerase; Enzyme","authors":[{"name":"Shaida A. Andrabi","is_ca":false},{"name":"No Soo Kim","is_ca":false},{"name":"Seong-Woon Yu","is_ca":false},{"name":"Hongmin Wang","is_ca":false},{"name":"David W. Koh","is_ca":false},{"name":"Masayuki Sasaki","is_ca":false},{"name":"Judith A. Klaus","is_ca":false},{"name":"Takashi Otsuka","is_ca":false},{"name":"Zhizheng Zhang","is_ca":false},{"name":"Raymond C. Koehler","is_ca":false},{"name":"Patricia D. Hurn","is_ca":false},{"name":"Guy G. Poirier","is_ca":true},{"name":"Valina L. Dawson","is_ca":false},{"name":"Ted M. Dawson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05115591992945612,"gpt":0.3345953264226731,"spread":0.283439406493217,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008041501,0.000383478,0.0002206291,0.000155632,0.0001611896,0.000469959,0.0001370243,0.0003076976,0.001361273],"category_scores_gemma":[0.00009154496,0.0001164399,0.0001991411,0.000139436,0.0002592618,0.0002428107,0.00022136,0.0005827234,0.0006988036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002396535,"about_ca_system_score_gemma":0.000109912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001246541,"about_ca_topic_score_gemma":0.0001396461,"domain_scores_codex":[0.9998975,0.00001187735,0.000006177163,0.000033349,0.00003266843,0.00001842005],"domain_scores_gemma":[0.9999235,0.000009166448,0.00003402071,0.000008158828,0.000008779613,0.00001645864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000928883,0.00001863489,0.0002687574,0.00005520402,0.00001086606,0.0001518052,0.000007705644,0.00007854361,0.9919892,0.0003250675,0.0001534399,0.006847976],"study_design_scores_gemma":[0.000009267663,0.0003643532,0.002666677,0.000005091538,0.00001382361,0.001082476,0.00001591503,0.0003274197,0.9864443,0.0001888762,0.008876845,0.000004858621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9253358,0.02616869,0.03884831,0.0009834438,0.0002391583,0.00006370416,0.0007408657,0.0005732371,0.007046682],"genre_scores_gemma":[0.9774817,0.01068678,0.006123635,0.0001864056,0.00006446455,0.00002559312,0.0007163445,0.00002540992,0.004689701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001361273,"threshold_uncertainty_score":0.004553914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070758111","doi":"10.1074/jbc.m706734200","title":"PARP1-dependent Kinetics of Recruitment of MRE11 and NBS1 Proteins to Multiple DNA Damage Sites","year":2007,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":599,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval; University of Alberta; Centre hospitalier universitaire de Québec","funders":"","keywords":"DNA damage; DNA; Kinetics; PARP1; Cell biology; Biology; Chemistry; Biophysics; Genetics; Poly ADP ribose polymerase; Physics; Polymerase","authors":[{"name":"Jean-François Haince","is_ca":true},{"name":"Darin McDonald","is_ca":true},{"name":"Amélie Rodrigue","is_ca":true},{"name":"Ugo Déry","is_ca":true},{"name":"Jean‐Yves Masson","is_ca":true},{"name":"Michael J. Hendzel","is_ca":true},{"name":"Guy G. Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1017277491476446,"gpt":0.3504430346639978,"spread":0.2487152855163532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001766491,0.0001391611,0.0002509819,0.0001428595,0.0001418135,0.000368256,0.00022357,0.0002859674,0.001960731],"category_scores_gemma":[0.0003324375,0.0002211822,0.0001370597,0.0001539587,0.0002215477,0.0004737479,0.0002179669,0.0006351873,0.000626581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003844297,"about_ca_system_score_gemma":0.0001255844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006393066,"about_ca_topic_score_gemma":0.0005450529,"domain_scores_codex":[0.9998415,0.00001449052,0.000008710168,0.00006412277,0.00003862533,0.00003256983],"domain_scores_gemma":[0.9997882,0.00006222352,0.00005388198,0.00002344935,0.00003195834,0.00004036128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000331398,0.00004023932,0.0006054673,0.00005236452,0.00000946807,0.000052841,0.00007128078,0.0003733446,0.9951022,0.0003009671,0.0002184937,0.002841832],"study_design_scores_gemma":[0.00001178933,0.0001125342,0.01001885,0.000005563124,0.000006942581,0.0001413447,0.00005234874,0.004164653,0.9831842,0.00010274,0.00218859,0.00001054411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984319,0.002631448,0.00997493,0.0001625674,0.00004172561,0.00002983545,0.0006419857,0.0001176353,0.002080736],"genre_scores_gemma":[0.9910528,0.00123492,0.00320723,0.00004976174,0.00001167157,0.00005937235,0.0007532664,0.00002686626,0.003604046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001960731,"threshold_uncertainty_score":0.006559253,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033816200","doi":"10.1016/s1470-2045(14)71135-0","title":"Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":544,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; Université Laval; Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Carboplatin; Tolerability; Internal medicine; Regimen; Ovarian cancer; Chemotherapy; Oncology; Paclitaxel; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Phases of clinical research; Urology; Cancer; Randomized controlled trial; Cisplatin; Adverse effect","authors":[{"name":"Amit M. Oza","is_ca":true},{"name":"David Cibula","is_ca":false},{"name":"Ana Oaknin Benzaquen","is_ca":false},{"name":"Christopher Poole","is_ca":false},{"name":"Ron H.J. Mathijssen","is_ca":false},{"name":"Gabe S. Sonke","is_ca":false},{"name":"Nicoletta Colombo","is_ca":false},{"name":"Jiří Špaček","is_ca":false},{"name":"Peter Vuylsteke","is_ca":false},{"name":"Holger W. Hirte","is_ca":true},{"name":"Sven Mahner","is_ca":false},{"name":"Marie Plante","is_ca":true},{"name":"Barbara Schmalfeldt","is_ca":false},{"name":"Helen Mackay","is_ca":true},{"name":"Jacqui Rowbottom","is_ca":false},{"name":"Elizabeth Lowe","is_ca":false},{"name":"Brian Dougherty","is_ca":false},{"name":"J. Carl Barrett","is_ca":false},{"name":"Michael Friedländer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05582660886094198,"gpt":0.3904644590514653,"spread":0.3346378501905233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001807734,0.002229034,0.003580784,0.0004732449,0.000429828,0.001552536,0.0009897881,0.002067053,0.009320953],"category_scores_gemma":[0.00259443,0.0009755517,0.002573171,0.0006235606,0.001681433,0.001620607,0.0007974948,0.004317354,0.00137701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001062983,"about_ca_system_score_gemma":0.001139053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001075262,"about_ca_topic_score_gemma":0.002102761,"domain_scores_codex":[0.9991542,0.0004834522,0.00004517959,0.0001528572,0.0000436585,0.0001206292],"domain_scores_gemma":[0.9988759,0.0004014331,0.0002204019,0.0001128063,0.00004053906,0.0003489516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9809524,0.002125431,0.000384229,0.0007354862,0.001010368,0.00004517558,0.00004989701,0.0004041727,0.0009703272,0.00009539831,0.0008562115,0.01237085],"study_design_scores_gemma":[0.9768296,0.02117477,0.0005764387,0.0000328423,0.0003847621,0.00003119622,0.00001687193,0.0001563369,0.00009491893,0.0001540914,0.0005377709,0.00001045833],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.968951,0.0136287,0.001320668,0.002646122,0.001694432,0.005184971,0.002715407,0.000235226,0.00362349],"genre_scores_gemma":[0.9733208,0.007589741,0.002059875,0.002741515,0.0007644061,0.00547319,0.00235141,0.00006268117,0.005636385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009320953,"threshold_uncertainty_score":0.03118169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2935541805","doi":"10.1016/s1470-2045(19)30029-4","title":"Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":537,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Ovarian cancer; BRCA mutation; Oncology; Progressive disease; Chemotherapy; Progression-free survival; Population; Phases of clinical research; Carboplatin; Combination therapy; Surgery; Gastroenterology; Cancer; Cisplatin","authors":[{"name":"Kathleen N. Moore","is_ca":false},{"name":"Angeles Alvarez Secord","is_ca":false},{"name":"Melissa A. Geller","is_ca":false},{"name":"David S. Miller","is_ca":false},{"name":"Noelle Cloven","is_ca":false},{"name":"Gini F. Fleming","is_ca":false},{"name":"Andrea E. Wahner Hendrickson","is_ca":false},{"name":"Masoud Azodi","is_ca":false},{"name":"Paul DiSilvestro","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Mihaela Cristea","is_ca":false},{"name":"Jonathan S. Berek","is_ca":false},{"name":"John K. Chan","is_ca":false},{"name":"B.J. Rimel","is_ca":false},{"name":"Daniela Matei","is_ca":false},{"name":"Yong Li","is_ca":false},{"name":"Kaiming Sun","is_ca":false},{"name":"Katarina Luptakova","is_ca":false},{"name":"Ursula A. Matulonis","is_ca":false},{"name":"Bradley J. Monk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2455515079193662,"gpt":0.4816545343169153,"spread":0.2361030263975491,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001928591,0.001705872,0.002393517,0.0003101255,0.0003283363,0.001262568,0.0009598502,0.001285685,0.006473244],"category_scores_gemma":[0.001351116,0.0005693685,0.002106661,0.0003232713,0.0009864734,0.001333527,0.0005211699,0.004241631,0.001454577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007561734,"about_ca_system_score_gemma":0.001069702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000469753,"about_ca_topic_score_gemma":0.001763358,"domain_scores_codex":[0.9995617,0.0002198275,0.00001800556,0.00009277234,0.0000292941,0.00007836062],"domain_scores_gemma":[0.9992812,0.0001526243,0.0001321538,0.00007870827,0.00003446132,0.0003209149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9027153,0.01189507,0.001600801,0.001299042,0.001930384,0.0001151338,0.0001324618,0.001486623,0.008514596,0.0004152358,0.005288338,0.06460706],"study_design_scores_gemma":[0.9092796,0.08368403,0.00268862,0.00004545389,0.0003594084,0.0001787627,0.00003254648,0.0007521539,0.0004609305,0.0003777174,0.002113242,0.0000275125],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976484,0.008809147,0.001442746,0.001918216,0.0007194831,0.003005103,0.003590187,0.0003080137,0.003723062],"genre_scores_gemma":[0.9720392,0.005386302,0.004150069,0.002833912,0.0004526132,0.003472902,0.004973596,0.00009775107,0.006593716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006473244,"threshold_uncertainty_score":0.02165514,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2799710201","doi":"10.1186/s40169-018-0185-6","title":"Analyses of repeated failures in cancer therapy for solid tumors: poor tumor‐selective drug delivery, low therapeutic efficacy and unsustainable costs","year":2018,"lang":"en","type":"article","venue":"Clinical and Translational Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":486,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Aging","funders":"National Eye Institute; National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology; National Cancer Institute; University of Pennsylvania","keywords":"Medicine; Cancer; Drug; Drug delivery; Cancer therapy; Oncology; Intensive care medicine; Pharmacology; Internal medicine; Nanotechnology","authors":[{"name":"Hiroshi Maeda","is_ca":false},{"name":"Mahin Khatami","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09298064257482087,"gpt":0.4585024538825066,"spread":0.3655218113076857,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02075465,0.000723093,0.001131118,0.002278389,0.0006276655,0.00258884,0.001002408,0.00070521,0.004123957],"category_scores_gemma":[0.04094004,0.0002245979,0.001246028,0.002757512,0.00142853,0.001886331,0.001297541,0.00130925,0.0006136125],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002850667,"about_ca_system_score_gemma":0.001589203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002494622,"about_ca_topic_score_gemma":0.001954592,"domain_scores_codex":[0.9773722,0.00849458,0.001689024,0.002269185,0.009512368,0.0006625524],"domain_scores_gemma":[0.9314703,0.03164154,0.02334623,0.004894209,0.007771792,0.0008759106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002100731,0.0005312745,0.6864685,0.00200709,0.00254004,0.001004192,0.0009407654,0.008848253,0.004322954,0.01508383,0.009473526,0.2666788],"study_design_scores_gemma":[0.0000685601,0.002170104,0.884618,0.0006308079,0.001966278,0.004145002,0.002307425,0.01487486,0.01285999,0.02907629,0.04708461,0.0001980393],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.8233206,0.05810065,0.06940374,0.01157976,0.0006729361,0.001084844,0.008280714,0.0003240488,0.02723279],"genre_scores_gemma":[0.9820127,0.004611649,0.007317103,0.0009952786,0.0002993789,0.0002993508,0.001337753,0.00007859914,0.00304827],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02075465,"threshold_uncertainty_score":0.1097624,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4295078726","doi":"10.1200/jco.22.01549","title":"Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":475,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; NRG Oncology; Sanofi; AstraZeneca","keywords":"Olaparib; Medicine; PARP inhibitor; Internal medicine; Ovarian cancer; Hazard ratio; Clinical endpoint; Oncology; Placebo; Cancer; Veliparib; BRCA mutation; Clinical trial; Surgery; Poly ADP ribose polymerase; Confidence interval; Pathology","authors":[{"name":"Paul DiSilvestro","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Nicoletta Colombo","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Byoung‐Gie Kim","is_ca":false},{"name":"Ana Oaknin","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Alla Lisyanskaya","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Alexandra Léary","is_ca":false},{"name":"Gabe S. Sonke","is_ca":false},{"name":"Charlie Gourley","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Antonio González-Martı́n","is_ca":false},{"name":"Carol Aghajanian","is_ca":false},{"name":"William H. Bradley","is_ca":false},{"name":"Cara Mathews","is_ca":false},{"name":"Joyce F. Liu","is_ca":false},{"name":"John McNamara","is_ca":false},{"name":"Elizabeth Lowe","is_ca":false},{"name":"Mei-Lin Ah-See","is_ca":false},{"name":"Kathleen N. Moore","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0555831528157147,"gpt":0.3980408485949811,"spread":0.3424576957792664,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002149116,0.0005701975,0.001385251,0.0002620814,0.0002355691,0.0007070623,0.0004890318,0.000779042,0.001186291],"category_scores_gemma":[0.001313074,0.0002025604,0.001465162,0.0003163923,0.0005277215,0.0005394711,0.000306844,0.00156211,0.0001541283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005593187,"about_ca_system_score_gemma":0.0007715046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003454811,"about_ca_topic_score_gemma":0.000981328,"domain_scores_codex":[0.9994091,0.0003608967,0.00003674633,0.00008483199,0.00004981773,0.00005870931],"domain_scores_gemma":[0.9990371,0.0002341392,0.0002946403,0.00008519957,0.00004664537,0.00030218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9367779,0.003094679,0.007288956,0.0004911647,0.001283744,0.00007674159,0.00007367761,0.0007563682,0.004392432,0.0001042085,0.0009552025,0.0447049],"study_design_scores_gemma":[0.7401344,0.215667,0.03613341,0.0001673669,0.001940881,0.000256501,0.00005593779,0.001553473,0.001514142,0.0004195086,0.002116,0.0000413679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939658,0.004306526,0.0001749519,0.0002264346,0.00008963064,0.0002922676,0.0003196911,0.0000200264,0.0006046867],"genre_scores_gemma":[0.9952095,0.001611715,0.00042678,0.0004348788,0.0001695327,0.0007008816,0.0007786092,0.000006080503,0.000662011],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002149116,"threshold_uncertainty_score":0.01136577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049028195","doi":"10.1126/scisignal.2000902","title":"Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos)","year":2011,"lang":"en","type":"article","venue":"Science Signaling","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":464,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Poly ADP ribose polymerase; Apoptosis; Programmed cell death; Polymerase; Cell biology; Biology; Molecular biology; Ribose; Cancer research; Chemistry; Biochemistry; Enzyme","authors":[{"name":"Yingfei Wang","is_ca":false},{"name":"No Soo Kim","is_ca":false},{"name":"Jean-François Haince","is_ca":true},{"name":"Ho Chul Kang","is_ca":false},{"name":"Karen K David","is_ca":false},{"name":"Shaida A. Andrabi","is_ca":false},{"name":"Guy G. Poirier","is_ca":true},{"name":"Valina L. Dawson","is_ca":true},{"name":"Ted M. Dawson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09824333107992472,"gpt":0.3517895159427005,"spread":0.2535461848627757,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001869399,0.0004370325,0.000343512,0.0001349378,0.0002899095,0.0004883259,0.0002752474,0.000407217,0.001772405],"category_scores_gemma":[0.0002520963,0.0001837895,0.0003491599,0.0001258735,0.0002573527,0.0005077834,0.0002782381,0.0008039564,0.0008403359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003977115,"about_ca_system_score_gemma":0.0002168593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002135194,"about_ca_topic_score_gemma":0.0002979849,"domain_scores_codex":[0.9997423,0.00004269078,0.00002176318,0.0000809741,0.00006211982,0.00005011199],"domain_scores_gemma":[0.9997572,0.00004235232,0.00009472408,0.0000335044,0.00002233018,0.00004990133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000102195,0.00002020363,0.00009915208,0.00002327007,0.000003449784,0.00006954565,0.000007517702,0.00002420362,0.9985298,0.0001372686,0.00002720098,0.0009561242],"study_design_scores_gemma":[0.00001449294,0.0002170402,0.007921069,0.000004426151,0.00001154788,0.0005766671,0.00002063941,0.0006165305,0.9868408,0.000120426,0.003650705,0.000005643173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9700549,0.006905272,0.01968115,0.0003759363,0.0001277294,0.00006280987,0.0003808643,0.0001990744,0.00221229],"genre_scores_gemma":[0.9890087,0.001767847,0.005192611,0.0001533034,0.00003227609,0.00006609784,0.0008773209,0.00002674884,0.002875058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001772405,"threshold_uncertainty_score":0.005929291,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085215116","doi":"10.1038/nbt.2121","title":"Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors","year":2012,"lang":"en","type":"article","venue":"Nature Biotechnology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":460,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Structural Genomics Consortium","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Olaparib; Poly ADP ribose polymerase; Polymerase; Small molecule; PARP inhibitor; Computational biology; Biology; Chemical biology; Chemistry; Biochemistry; Enzyme; Genetics","authors":[{"name":"E. Wahlberg","is_ca":true},{"name":"T. Karlberg","is_ca":false},{"name":"E. Kouznetsova","is_ca":true},{"name":"Natalia Markova","is_ca":true},{"name":"Antonio Macchiarulo","is_ca":false},{"name":"A.G. Thorsell","is_ca":false},{"name":"Ewa Pol","is_ca":false},{"name":"Åsa Frostell","is_ca":false},{"name":"T. Ekblad","is_ca":false},{"name":"Delal Öncü","is_ca":false},{"name":"Björn Kull","is_ca":false},{"name":"G.M. Robertson","is_ca":false},{"name":"Roberto Pellicciari","is_ca":false},{"name":"H. Schüler","is_ca":false},{"name":"Johan Weigelt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008652512575361737,"gpt":0.2946905990793961,"spread":0.2860380865040343,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000194093,0.0002931405,0.0003914993,0.0006510051,0.0002168852,0.0002619752,0.0003322512,0.0002552535,0.001861587],"category_scores_gemma":[0.0002920901,0.000168168,0.0005355059,0.0007159433,0.0001429421,0.0002742567,0.0001596126,0.0004482774,0.0004700161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004483615,"about_ca_system_score_gemma":0.0002544398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00113206,"about_ca_topic_score_gemma":0.002354853,"domain_scores_codex":[0.9998825,0.0000125102,0.000007745256,0.00002723196,0.00005009627,0.00002003055],"domain_scores_gemma":[0.9998535,0.0000224927,0.00005595536,0.00001445589,0.00003577688,0.0000178782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005661593,0.00005942963,0.003028396,0.0001015336,0.000117819,0.0001314736,0.00003202291,0.001662025,0.9817728,0.0001658623,0.0004853576,0.01187707],"study_design_scores_gemma":[0.00008722899,0.001019783,0.04037658,0.00001355988,0.0003346956,0.001936224,0.0001186806,0.007408669,0.9332621,0.0002979943,0.01511004,0.00003442754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9804183,0.006241454,0.004097888,0.0003064808,0.00001592975,0.00005886322,0.005487561,0.0001600712,0.003213495],"genre_scores_gemma":[0.9771885,0.004441451,0.005810095,0.0001992685,0.00001575307,0.00004358091,0.009100744,0.000055096,0.003145532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001861587,"threshold_uncertainty_score":0.006227672,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4304084160","doi":"10.1016/j.annonc.2022.09.159","title":"Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Merck Sharp and Dohme; University of Illinois at Urbana-Champaign; National Institutes of Health; Karolinska Institutet; Clovis Oncology; National Institute for Health and Care Research; Seagen; Cilag; Puma Biotechnology; NRG Oncology; Les Laboratories Pierre Fabre; Institut Bergonié; Amgen; Rush University; University of Pennsylvania; Genentech; Institut Gustave-Roussy; Merck KGaA; Daiichi Sankyo Europe; National Cancer Institute; Servier; Gilead Sciences; School of Medicine, Indiana University; European Commission; Sanofi; Genomic Health; Ochsner Health; MSD; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Olaparib; Internal medicine; Oncology; Placebo; Hazard ratio; Breast cancer; Confidence interval; Cancer; Pathology; Biology; Polymerase","authors":[{"name":"Charles E. Geyer","is_ca":false},{"name":"Judy E. Garber","is_ca":false},{"name":"Richard D. Gelber","is_ca":false},{"name":"Greg Yothers","is_ca":false},{"name":"Manuel Taboada","is_ca":false},{"name":"L. Ross","is_ca":false},{"name":"Priya Rastogi","is_ca":false},{"name":"Karen Cui","is_ca":false},{"name":"Amal Arahmani","is_ca":false},{"name":"Gursel Aktan","is_ca":false},{"name":"Anne Armstrong","is_ca":false},{"name":"Mónica Arnedos","is_ca":false},{"name":"Judith Balmaña","is_ca":false},{"name":"Jonas Bergh","is_ca":false},{"name":"Judith M. Bliss","is_ca":false},{"name":"Suzette Delaloge","is_ca":false},{"name":"Susan M. Domchek","is_ca":false},{"name":"Andrea Eisen","is_ca":true},{"name":"F. Elsafy","is_ca":false},{"name":"L.E. Fein","is_ca":false},{"name":"Anitra Fielding","is_ca":false},{"name":"James M. Ford","is_ca":false},{"name":"Sue Friedman","is_ca":false},{"name":"Karen A. Gelmon","is_ca":false},{"name":"Luca Gianni","is_ca":false},{"name":"Michael Gnant","is_ca":false},{"name":"Simon J. Hollingsworth","is_ca":false},{"name":"Seock‐Ah Im","is_ca":false},{"name":"Agnes Jager","is_ca":false},{"name":"Oskar T. Johannsson","is_ca":false},{"name":"Sunil R. Lakhani","is_ca":false},{"name":"W Janni","is_ca":false},{"name":"Barbro Linderholm","is_ca":false},{"name":"T.-W. Liu","is_ca":false},{"name":"Niklas Loman","is_ca":false},{"name":"Larissa A. Korde","is_ca":false},{"name":"Sibylle Loibl","is_ca":false},{"name":"Peter C. Lucas","is_ca":false},{"name":"Frederik Marmé","is_ca":false},{"name":"E. Martinez de Dueñas","is_ca":false},{"name":"Robin McConnell","is_ca":false},{"name":"Kelly‐Anne Phillips","is_ca":false},{"name":"Martine Piccart","is_ca":false},{"name":"Giovanna Rossi","is_ca":false},{"name":"Rita K. Schmutzler","is_ca":false},{"name":"Elżbieta Senkus","is_ca":false},{"name":"Zhi-Ming Shao","is_ca":false},{"name":"Priyanka Sharma","is_ca":false},{"name":"Christian F. Singer","is_ca":false},{"name":"Tanja Španić","is_ca":false},{"name":"Elmar Stickeler","is_ca":false},{"name":"Masakazu Toi","is_ca":false},{"name":"Tiffany A. Traina","is_ca":false},{"name":"Giuseppe Viale","is_ca":false},{"name":"Gabriele Zoppoli","is_ca":false},{"name":"Y.H. Park","is_ca":false},{"name":"Rinat Yerushalmi","is_ca":false},{"name":"Huan Yang","is_ca":false},{"name":"D. Pang","is_ca":false},{"name":"Kyung Hae Jung","is_ca":false},{"name":"Audrey Mailliez","is_ca":false},{"name":"Zhaoqing Fan","is_ca":false},{"name":"Isabelle Tennevet","is_ca":false},{"name":"J. Zhang","is_ca":false},{"name":"T. Nagy","is_ca":false},{"name":"Gabe S. Sonke","is_ca":false},{"name":"Qiuhong Sun","is_ca":false},{"name":"Marina Parton","is_ca":false},{"name":"Marco Colleoni","is_ca":false},{"name":"Marcus Schmidt","is_ca":false},{"name":"Adam Brufsky","is_ca":false},{"name":"W. Razaq","is_ca":false},{"name":"Bella Kaufman","is_ca":false},{"name":"David Cameron","is_ca":false},{"name":"Christine Campbell","is_ca":false},{"name":"Andrew Tutt","is_ca":false},{"name":"P. Sevelda","is_ca":false},{"name":"Ferdinand Haslbauer","is_ca":false},{"name":"Monika Penzinger","is_ca":false},{"name":"Leopold Öhler","is_ca":false},{"name":"Christoph Tinchon","is_ca":false},{"name":"Richard Greil","is_ca":false},{"name":"Sonja Heibl","is_ca":false},{"name":"Rupert Bartsch","is_ca":false},{"name":"Viktor Wette","is_ca":false},{"name":"Claudia Pasterk","is_ca":false},{"name":"Ruth Helfgott","is_ca":false},{"name":"Gunda Pristauz-Telsnigg","is_ca":false},{"name":"Herbert Stöger","is_ca":false},{"name":"A. Weltermann","is_ca":false},{"name":"Daniel Egle","is_ca":false},{"name":"I. Thiel","is_ca":false},{"name":"David Fuchs","is_ca":false},{"name":"Holger Rumpold","is_ca":false},{"name":"Kathrin Strasser‐Weippl","is_ca":false},{"name":"Beate Rautenberg","is_ca":false},{"name":"Volkmar Müller","is_ca":false},{"name":"Stefan Paepke","is_ca":false},{"name":"Mustafa Aydoğdu","is_ca":false},{"name":"Christoph Thomssen","is_ca":false},{"name":"Joachim Rom","is_ca":false},{"name":"Christine Mau","is_ca":false},{"name":"Peter A. Fasching","is_ca":false},{"name":"Uwe-Jochen Göhring","is_ca":false},{"name":"Thorsten Kühn","is_ca":false},{"name":"S Noeding","is_ca":false},{"name":"Sherko Kümmel","is_ca":false},{"name":"John Hackmann","is_ca":false},{"name":"Abhishek Joshi","is_ca":false},{"name":"Joanna Dewar","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Yoland Antill","is_ca":false},{"name":"Natasha Woodward","is_ca":false},{"name":"Ehtesham Abdi","is_ca":false},{"name":"Susan Tiley","is_ca":false},{"name":"Mathew George","is_ca":false},{"name":"David Boadle","is_ca":false},{"name":"Annabel Goodwin","is_ca":false},{"name":"André van der Westhuizen","is_ca":false},{"name":"George Kannourakis","is_ca":false},{"name":"N. Murray","is_ca":false},{"name":"Nicole McCarthy","is_ca":false},{"name":"Judith R. Kroep","is_ca":false},{"name":"Maaike de Boer","is_ca":false},{"name":"Joan B. Heijns","is_ca":false},{"name":"Franciscus Erdkamp","is_ca":false},{"name":"Sandra D. Bakker","is_ca":false},{"name":"Amer Sami","is_ca":false},{"name":"John M. Mackey","is_ca":false},{"name":"Catherine Prady","is_ca":false},{"name":"Christine Desbiens","is_ca":false},{"name":"Érica Patocskai","is_ca":false},{"name":"Cristiano Ferrario","is_ca":false},{"name":"Louise Bordeleau","is_ca":false},{"name":"Haji Chalchal","is_ca":false},{"name":"Saroj Niraula","is_ca":false},{"name":"Ido Wolf","is_ca":false},{"name":"François Duhoux","is_ca":false},{"name":"Randal D’hondt","is_ca":false},{"name":"Sylvie Luce","is_ca":false},{"name":"Konstantinos Papadimitriou","is_ca":false},{"name":"Marleen Borms","is_ca":false},{"name":"Claire Quaghebeur","is_ca":false},{"name":"William Jacot","is_ca":false},{"name":"Etienne Brain","is_ca":false},{"name":"Laurence Venat‐Bouvet","is_ca":false},{"name":"Alain Lortholary","is_ca":false},{"name":"Zbigniew Nowecki","is_ca":false},{"name":"Fátima Cardoso","is_ca":false},{"name":"Richard Hayward","is_ca":false},{"name":"Santiago Bella","is_ca":false},{"name":"Mauricio Fernández Lazzaro","is_ca":false},{"name":"N. Pilnik","is_ca":false},{"name":"Luis Fein","is_ca":false},{"name":"C. Blajman","is_ca":false},{"name":"Guillermo Lerzo","is_ca":false},{"name":"Mirta Varela","is_ca":false},{"name":"Juan José Zarbá","is_ca":false},{"name":"Diego Kaen","is_ca":false},{"name":"Maria Victoria Constanzo","is_ca":false},{"name":"Joke Tio","is_ca":false},{"name":"Wulf Siggelkow","is_ca":false},{"name":"Christian Jackisch","is_ca":false},{"name":"Eva Maria Grischke","is_ca":false},{"name":"D.-M. Zahm","is_ca":false},{"name":"Sara Tato-Varela","is_ca":false},{"name":"Sabine Schmatloch","is_ca":false},{"name":"Peter Klare","is_ca":false},{"name":"Andrea Stefek","is_ca":false},{"name":"Kerstin Rhiem","is_ca":false},{"name":"Oliver Hoffmann","is_ca":false},{"name":"Mustafa Deryal","is_ca":false},{"name":"Isolde Gröll","is_ca":false},{"name":"P. Ledwon","is_ca":false},{"name":"Christoph Uleer","is_ca":false},{"name":"Petra Krabisch","is_ca":false},{"name":"Jochem Potenberg","is_ca":false},{"name":"Maren Darsow","is_ca":false},{"name":"Tjoung‐Won Park‐Simon","is_ca":false},{"name":"Heinz‐Gert Höffkes","is_ca":false},{"name":"Till‐Oliver Emde","is_ca":false},{"name":"Gerd Graffunder","is_ca":false},{"name":"Oliver Tomé","is_ca":false},{"name":"Dirk Forstmeyer","is_ca":false},{"name":"Jürgen Terhaag","is_ca":false},{"name":"Christoph Salat","is_ca":false},{"name":"Karin Kast","is_ca":false},{"name":"Steffi Weniger","is_ca":false},{"name":"Carsten Schreiber","is_ca":false},{"name":"Bernhard Heinrich","is_ca":false},{"name":"Max Dieterich","is_ca":false},{"name":"Michaela Penelope Wüllner","is_ca":false},{"name":"Raquel Andrés Conejero","is_ca":false},{"name":"José Á. García-Sáenz","is_ca":false},{"name":"Angels Arcusa Lanza","is_ca":false},{"name":"Fernando Henao","is_ca":false},{"name":"Salvador Blanch Tormo","is_ca":false},{"name":"Juan Ignacio Delgado Mingorance","is_ca":false},{"name":"Elena Álvarez Gomez","is_ca":false},{"name":"Marta Santisteban","is_ca":false},{"name":"Josefina Cruz Jurado","is_ca":false},{"name":"Vanesa Quiroga","is_ca":false},{"name":"Manuel Ruiz Borrego","is_ca":false},{"name":"Eduardo Martínez de Dueñas","is_ca":false},{"name":"Jose Enrique Alés Martínez","is_ca":false},{"name":"Juan de la Haba-Rodríguez","is_ca":false},{"name":"Noelia Martínez-Jáñez","is_ca":false},{"name":"Álvaro Rodríguez Lescure","is_ca":false},{"name":"Gema Llort Crusades","is_ca":false},{"name":"Santiago González-Santiago","is_ca":false},{"name":"Antonia Marquez Aragones","is_ca":false},{"name":"Ana Laura Ortega Granados","is_ca":false},{"name":"A. Barnadas Molins","is_ca":false},{"name":"José Ignacio Chacón","is_ca":false},{"name":"M. Martín Jiménez","is_ca":false},{"name":"Ana Santaballa Bertrán","is_ca":false},{"name":"C. Rodríguez Rodríguez","is_ca":false},{"name":"Lucía González Cortijo","is_ca":false},{"name":"Elisabetta Cretella","is_ca":false},{"name":"Laura Cortesi","is_ca":false},{"name":"Enzo Maria Ruggeri","is_ca":false},{"name":"Claudio Verusio","is_ca":false},{"name":"Stefania Gori","is_ca":false},{"name":"Andrea Bonetti","is_ca":false},{"name":"Anna Maria Mosconi","is_ca":false},{"name":"Guy Jérusalem","is_ca":false},{"name":"Patrick Neven","is_ca":false},{"name":"Tünde Nagy","is_ca":false},{"name":"Graziella Pinotti","is_ca":false},{"name":"Antônio Bernardo","is_ca":false},{"name":"Eugênio Bucci","is_ca":false},{"name":"Laura Biganzoli","is_ca":false},{"name":"Konstantin J. Dedes","is_ca":false},{"name":"Urban Novak","is_ca":false},{"name":"Khalil Zaman","is_ca":false},{"name":"Jeremy Braybrooke","is_ca":false},{"name":"Matthew Winter","is_ca":false},{"name":"Daniel Rea","is_ca":false},{"name":"Muireann Kelleher","is_ca":false},{"name":"Sophie Barrett","is_ca":false},{"name":"Stephen L. Chan","is_ca":false},{"name":"Tamas Hickish","is_ca":false},{"name":"Jane Hurwitz","is_ca":false},{"name":"John Conibear","is_ca":false},{"name":"A. Jegannathen","is_ca":false},{"name":"R. Allerton","is_ca":false},{"name":"Annabel Borley","is_ca":false},{"name":"Ellen Copson","is_ca":false},{"name":"N C Levitt","is_ca":false},{"name":"Jean Abraham","is_ca":false},{"name":"Timothy Perren","is_ca":false},{"name":"Rebecca Roylance","is_ca":false},{"name":"Kazushige Ishida","is_ca":false},{"name":"Tatsuya Toyama","is_ca":false},{"name":"Norikazu Masuda","is_ca":false},{"name":"Junichiro Watanabe","is_ca":false},{"name":"Eriko Tokunaga","is_ca":false},{"name":"Takayuki Kinoshita","is_ca":false},{"name":"Yoshiaki Rai","is_ca":false},{"name":"Masahiro Takada","is_ca":false},{"name":"Yasuhiro Yanagita","is_ca":false},{"name":"Rikiya Nakamura","is_ca":false},{"name":"Takahiro Nakayama","is_ca":false},{"name":"Yasuto Naoi","is_ca":false},{"name":"Hiroji Iwata","is_ca":false},{"name":"Seigo Nakamura","is_ca":false},{"name":"Masato Takahashi","is_ca":false},{"name":"Kenjiro Aogi","is_ca":false},{"name":"Koichiro Tsugawa","is_ca":false},{"name":"Hirofumi Mukai","is_ca":false},{"name":"Toshimi Takano","is_ca":false},{"name":"Akihiko Osaki","is_ca":false},{"name":"Nobuaki Sato","is_ca":false},{"name":"Hideko Yamauchi","is_ca":false},{"name":"Yutaka Tokuda","is_ca":false},{"name":"Mitsuya Ito","is_ca":false},{"name":"Takeki Sugimoto","is_ca":false},{"name":"Shakeela Bahadur","is_ca":false},{"name":"Patricia A. Ganz","is_ca":false},{"name":"Min J. Lu","is_ca":false},{"name":"Monica Mita","is_ca":false},{"name":"James Waisman","is_ca":false},{"name":"Melinda L. Telli","is_ca":false},{"name":"Samantha A. Seaward","is_ca":false},{"name":"Jennifer M. Suga","is_ca":false},{"name":"Lara N. Durna","is_ca":false},{"name":"Jennifer Fu Carney","is_ca":false},{"name":"Alex R. Menter","is_ca":false},{"name":"Ajithkumar Puthillath","is_ca":false},{"name":"Nitin Rohatgi","is_ca":false},{"name":"Jonathan A. Polikoff","is_ca":false},{"name":"James H. Feusner","is_ca":false},{"name":"Kristie Bobolis","is_ca":false},{"name":"Peter D. Eisenberg","is_ca":false},{"name":"Jonathan A. Polikoff","is_ca":false},{"name":"Derrick Wong","is_ca":false},{"name":"Virginia F. Borges","is_ca":false},{"name":"Alexander T. Urquhart","is_ca":false},{"name":"Erin Hofstatter","is_ca":false},{"name":"Edward C. McCarron","is_ca":false},{"name":"Claudine Isaacs","is_ca":false},{"name":"Pia Herbolsheimer","is_ca":false},{"name":"Ramya Varadarajan","is_ca":false},{"name":"Adam Raben","is_ca":false},{"name":"Ruby Anne E. Deveras","is_ca":false},{"name":"Frances Valdes-Albini","is_ca":false},{"name":"Reshma L. Mahtani","is_ca":false},{"name":"Jane Meisel","is_ca":false},{"name":"Bradley T. Sumrall","is_ca":false},{"name":"Cheryl Jones","is_ca":false},{"name":"Samuel Ofori","is_ca":false},{"name":"Kenneth N.M. Sumida","is_ca":false},{"name":"Mark Karwal","is_ca":false},{"name":"Deborah W. Wilbur","is_ca":false},{"name":"Singh","is_ca":false},{"name":"David Spector","is_ca":false},{"name":"John M. Schallenkamp","is_ca":false},{"name":"Douglas E. Merkel","is_ca":false},{"name":"Shelly S. Lo","is_ca":false},{"name":"Pam Khosla","is_ca":false},{"name":"Massimo Cristofanilli","is_ca":false},{"name":"Lisa Flaum","is_ca":false},{"name":"Kent Hoskins","is_ca":false},{"name":"Melody Cobleigh","is_ca":false},{"name":"Elyse A. Lambiase","is_ca":false},{"name":"Olwen Hahn","is_ca":false},{"name":"Ira A. Oliff","is_ca":false},{"name":"Bryan A. Faller","is_ca":false},{"name":"James L. Wade","is_ca":false},{"name":"Nafisa Burhani","is_ca":false},{"name":"Amaryllis Gil","is_ca":false},{"name":"Harvey Einhorn","is_ca":false},{"name":"A.M. Storniolo","is_ca":false},{"name":"Brian K. Chang","is_ca":false},{"name":"Maitri Kalra","is_ca":false},{"name":"Erwin Robin","is_ca":false},{"name":"Bilal Ansari","is_ca":false},{"name":"Shaker R. Dakhil","is_ca":false},{"name":"Richard L. Deming","is_ca":false},{"name":"John T. Cole","is_ca":false},{"name":"David S. Hanson","is_ca":false},{"name":"Augusto C. Ochoa","is_ca":false},{"name":"Judy E. Garber","is_ca":false},{"name":"Harvey Zimbler","is_ca":false},{"name":"Deborah K. Armstrong","is_ca":false},{"name":"Katherine H. R. Tkaczuk","is_ca":false},{"name":"David Riseberg","is_ca":false},{"name":"Brian O’Connor","is_ca":false},{"name":"Dana Zakalik","is_ca":false},{"name":"Cynthia Vakhariya","is_ca":false},{"name":"Anne F. Schott","is_ca":false},{"name":"Michael S. Simon","is_ca":false},{"name":"Thomas J. Doyle","is_ca":false},{"name":"Tareq Al Baghdadi","is_ca":false},{"name":"Amy VanderWoude","is_ca":false},{"name":"Patrick J. Flynn","is_ca":false},{"name":"Bret Edward Buckley Friday","is_ca":false},{"name":"Kathryn J. Ruddy","is_ca":false},{"name":"Ron Smith","is_ca":false},{"name":"Ademuyiwa","is_ca":false},{"name":"Foluso Olabisi","is_ca":false},{"name":"Robert Ellis","is_ca":false},{"name":"Marchello","is_ca":false},{"name":"Tania Benjamin","is_ca":false},{"name":"Edward A. Levine","is_ca":false},{"name":"P. Kelly Marcom","is_ca":false},{"name":"C. Harkness","is_ca":false},{"name":"Antoinette R. Tan","is_ca":false},{"name":"W. Charles","is_ca":false},{"name":"Charles Kuzma","is_ca":false},{"name":"Shonda Asaad","is_ca":false},{"name":"James E. Radford","is_ca":false},{"name":"Preston D. Steen","is_ca":false},{"name":"Madhu Unnikrishnan","is_ca":false},{"name":"Grant R. Seeger","is_ca":false},{"name":"Kirsten M.H. Leu","is_ca":false},{"name":"Mehmet S Copur","is_ca":false},{"name":"Gamini S. Soori","is_ca":false},{"name":"Bradley A. Arrick","is_ca":false},{"name":"Jennifer G. Reeder","is_ca":false},{"name":"Deborah Toppmeyer","is_ca":false},{"name":"Zoneddy Dayao","is_ca":false},{"name":"Sylvia Adams","is_ca":false},{"name":"Eleni Andreopoulou","is_ca":false},{"name":"Magnuson Allison","is_ca":false},{"name":"Jesus D. Anampa Mesias","is_ca":false},{"name":"Ruby Sharma","is_ca":false},{"name":"Bhuvaneswari Ramaswamy","is_ca":false},{"name":"Aaron T. Gerds","is_ca":false},{"name":"Howard M. Gross","is_ca":false},{"name":"Shruti Trehan","is_ca":false},{"name":"Robert R. Shenk","is_ca":false},{"name":"Wajeeha Razaq","is_ca":false},{"name":"Abdul Mansoor","is_ca":false},{"name":"Christie Hilton","is_ca":false},{"name":"Chanh Huynh","is_ca":false},{"name":"Nabila Chowdhury","is_ca":false},{"name":"Susan M. Domchek","is_ca":false},{"name":"Elin R. Sigurdson","is_ca":false},{"name":"Terrence P. Cescon","is_ca":false},{"name":"Marc A. Rovito","is_ca":false},{"name":"Albert S. DeNittis","is_ca":false},{"name":"Victor G. Vogel","is_ca":false},{"name":"Thomas B. Julian","is_ca":false},{"name":"Lucy Boyle","is_ca":false},{"name":"Luis Báez-Díaz","is_ca":false},{"name":"FRANK BRESCIA","is_ca":false},{"name":"John E. Doster","is_ca":false},{"name":"Robert D. Siegel","is_ca":false},{"name":"Lucas Wong","is_ca":false},{"name":"Tejal Patel","is_ca":false},{"name":"Julie R. Nangia","is_ca":false},{"name":"Catherine A. Jones","is_ca":false},{"name":"George M. Cannon","is_ca":false},{"name":"Harry D. Bear","is_ca":false},{"name":"Hetal Vachhani","is_ca":false},{"name":"Mary Wilkinson","is_ca":false},{"name":"Marie E. Wood","is_ca":false},{"name":"Fengting Yan","is_ca":false},{"name":"Xingwei Sui","is_ca":false},{"name":"Carol M. van Haelst","is_ca":false},{"name":"Jennifer M. Specht","is_ca":false},{"name":"Ying Zhuo","is_ca":false},{"name":"Rubina Qamar","is_ca":false},{"name":"Matthew L. Ryan","is_ca":false},{"name":"Abigail L. Stockham","is_ca":false},{"name":"Shamsuddin Virani","is_ca":false},{"name":"Arlene A. Gayle","is_ca":false},{"name":"Steven J. Jubelirer","is_ca":false},{"name":"Sobha Kurian","is_ca":false},{"name":"Mohamad A. Salkeni","is_ca":false},{"name":"Gustav Silander","is_ca":false},{"name":"Anna‐Lotta Hallbeck","is_ca":false},{"name":"Anna von Wachenfeldt Väppling","is_ca":false},{"name":"Elsa Curtit","is_ca":false},{"name":"Catarina Cardoso","is_ca":false},{"name":"Sofía Braga","is_ca":false},{"name":"Miguel Abreu","is_ca":false},{"name":"Mafalda Casa-Nova","is_ca":false},{"name":"Mónica Nave","is_ca":false},{"name":"Eva María Ciruelos Gil","is_ca":false},{"name":"Judith Balmaña Gelpí","is_ca":false},{"name":"A. Fernandez Ortega","is_ca":false},{"name":"Josep Gumà Padró","is_ca":false},{"name":"B. Bermejo De Las Heras","is_ca":false},{"name":"María González Cao","is_ca":false},{"name":"Juan Cueva Bañuelos","is_ca":false},{"name":"Gemma Viñas Villaró","is_ca":false},{"name":"L Estevez","is_ca":false},{"name":"Jens Huober","is_ca":false},{"name":"Steffi Busch","is_ca":false},{"name":"Tanja Fehm","is_ca":false},{"name":"Antje Hahn","is_ca":false},{"name":"Andrea Gräfe","is_ca":false},{"name":"Thomas Noesselt","is_ca":false},{"name":"Thomas Dewitz","is_ca":false},{"name":"Harald Wagner","is_ca":false},{"name":"Christina Bechtner","is_ca":false},{"name":"Michael Weigel","is_ca":false},{"name":"Hans‐Christian Kolberg","is_ca":false},{"name":"Thomas Decker","is_ca":false},{"name":"Jörg Thomalla","is_ca":false},{"name":"Tobias Hesse","is_ca":false},{"name":"Nadia Harbeck","is_ca":false},{"name":"Jan Schröder Jens-Uwe Blohmer","is_ca":false},{"name":"Marc Sütterlin","is_ca":false},{"name":"Renske Altena","is_ca":false},{"name":"Chang-Fang Chiu","is_ca":false},{"name":"Shin‐Cheh Chen","is_ca":false},{"name":"Ming‐Feng Hou","is_ca":false},{"name":"Yuan‐Ching Chang","is_ca":false},{"name":"Shang‐Hung Chen","is_ca":false},{"name":"Shou-Tung Chen","is_ca":false},{"name":"Chiun‐Sheng Huang","is_ca":false},{"name":"Dah‐Cherng Yeh","is_ca":false},{"name":"Jyh-Cherng Yu","is_ca":false},{"name":"Ling‐Ming Tseng","is_ca":false},{"name":"Wei‐Pang Chung","is_ca":false},{"name":"Thierry Petit","is_ca":false},{"name":"Suzette Delaloge","is_ca":false},{"name":"Christelle Lévy","is_ca":false},{"name":"P. Dalivoust","is_ca":false},{"name":"Jean-Marc Extra","is_ca":false},{"name":"Marie‐Ange Mouret‐Reynier","is_ca":false},{"name":"Anne‐Claire Hardy‐Bessard","is_ca":false},{"name":"H. Simon","is_ca":false},{"name":"Tiffenn L'Haridon","is_ca":false},{"name":"Alice Mège","is_ca":false},{"name":"Sylvie Giacchetti","is_ca":false},{"name":"Camille Chakiba-Brugère","is_ca":false},{"name":"Alain Gratet","is_ca":false},{"name":"V. Pottier","is_ca":false},{"name":"Jean-­Marc Ferrero","is_ca":false},{"name":"Christophe Perrin","is_ca":false},{"name":"Jean-Luc Canon","is_ca":false},{"name":"Sofie Joris","is_ca":false},{"name":"Zhimin Shao","is_ca":false},{"name":"Binghe Xu","is_ca":false},{"name":"ZeFei Jiang","is_ca":false},{"name":"Qiang Sun","is_ca":false},{"name":"Kunwei Shen","is_ca":false},{"name":"Da Pang","is_ca":false},{"name":"Jin Zhang","is_ca":false},{"name":"Shui Wang","is_ca":false},{"name":"Hongjian Yang","is_ca":false},{"name":"Ning Liao","is_ca":false},{"name":"Hong Zheng","is_ca":false},{"name":"Peifen Fu","is_ca":false},{"name":"Chuangui Song","is_ca":false},{"name":"Yongsheng Wang","is_ca":false},{"name":"Zhimin Fan","is_ca":false},{"name":"Cuizhi Geng","is_ca":false},{"name":"Olivier Trédan","is_ca":false},{"name":"László Landherr","is_ca":false},{"name":"Beatrice Uziely","is_ca":false},{"name":"PierFranco Conte","is_ca":false},{"name":"Claudio Zamagni","is_ca":false},{"name":"Giampaolo Bianchini","is_ca":false},{"name":"Michelino De Laurentiis","is_ca":false},{"name":"Carlo Tondini","is_ca":false},{"name":"Vittorio Gebbia","is_ca":false},{"name":"Mariangela Ciccarese","is_ca":false},{"name":"Tomasz Sarosiek","is_ca":false},{"name":"Jacek Mackiewicz","is_ca":false},{"name":"Anna Słowińska","is_ca":false},{"name":"Ewa Kalinka‐Warzocha","is_ca":false},{"name":"Tomasz Huzarski","is_ca":false},{"name":"Joohyuk Sohn","is_ca":false},{"name":"Jee Hyun Kim","is_ca":false},{"name":"Keun Seok Lee","is_ca":false},{"name":"Kyoung Eun Lee","is_ca":false},{"name":"Yee Soo Chae","is_ca":false},{"name":"Eun Kyung Cho","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03810809554894744,"gpt":0.3551060294228056,"spread":0.3169979338738582,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003075093,0.001118322,0.001970916,0.0002702487,0.0002858786,0.001040233,0.0007080788,0.0009529863,0.002319061],"category_scores_gemma":[0.002174941,0.0005142424,0.002049236,0.0002596727,0.0007809515,0.0006114746,0.0005409378,0.002266372,0.0003425115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000730415,"about_ca_system_score_gemma":0.001256403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005127332,"about_ca_topic_score_gemma":0.001409276,"domain_scores_codex":[0.999015,0.0006039062,0.00005401434,0.0001276304,0.00006729614,0.0001320654],"domain_scores_gemma":[0.9989054,0.000262889,0.000356339,0.00009231933,0.00006238506,0.0003206291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9800984,0.002646885,0.00279846,0.0002457963,0.0006636032,0.00002716938,0.00003099862,0.0004237086,0.00165509,0.00006064595,0.0006392426,0.01071],"study_design_scores_gemma":[0.9061911,0.08241545,0.008626021,0.0000495813,0.0007777688,0.00005755043,0.00002278297,0.0005575832,0.0004089964,0.0001359474,0.0007452275,0.00001192938],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938304,0.002747786,0.0002803431,0.0004053595,0.0002680342,0.0008561442,0.0004859168,0.00003475257,0.001091416],"genre_scores_gemma":[0.992332,0.001462702,0.0006820057,0.0008399188,0.0003519467,0.001678789,0.001204346,0.0000109635,0.001437442],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003075093,"threshold_uncertainty_score":0.01626283,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901506506","doi":"10.1158/2159-8290.cd-18-0715","title":"<i>BRCA</i> Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Reversion; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Ovarian carcinoma; Mutation; Ovarian cancer; Biology; DNA; Genetics; Medicine; Oncology; Cancer; Polymerase; Gene; Phenotype","authors":[{"name":"Kevin Lin","is_ca":false},{"name":"Maria I. Harrell","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Ana Oaknin","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Anna V. Tinker","is_ca":true},{"name":"Elena Helman","is_ca":false},{"name":"Marc R. Radke","is_ca":false},{"name":"Carmen Say","is_ca":false},{"name":"Lan-Thanh Vo","is_ca":false},{"name":"Elaina Mann","is_ca":false},{"name":"Jeffrey D. Isaacson","is_ca":false},{"name":"Lara Maloney","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Setsuko K. Chambers","is_ca":false},{"name":"Scott H. Kaufmann","is_ca":false},{"name":"Clare L. Scott","is_ca":false},{"name":"Gottfried E. Konecny","is_ca":false},{"name":"Robert L. Coleman","is_ca":false},{"name":"James Sun","is_ca":false},{"name":"Heidi Giordano","is_ca":false},{"name":"James D. Brenton","is_ca":false},{"name":"Thomas C. Harding","is_ca":false},{"name":"Iain A. McNeish","is_ca":false},{"name":"Elizabeth M. Swisher","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0169701192130969,"gpt":0.2694381824583575,"spread":0.2524680632452607,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001986308,0.0001655613,0.0001980312,0.0004280497,0.0001519342,0.0003215858,0.0001441647,0.0003289297,0.002011731],"category_scores_gemma":[0.001361368,0.0001159406,0.00009627797,0.0002143115,0.0001668896,0.0001582775,0.0001185982,0.0002677515,0.0001787706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002299452,"about_ca_system_score_gemma":0.0001377332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001210165,"about_ca_topic_score_gemma":0.00139343,"domain_scores_codex":[0.9998941,0.00001747951,0.00001196901,0.00003329258,0.00002277965,0.00002043796],"domain_scores_gemma":[0.9993874,0.000268698,0.0001597546,0.00003081194,0.00006372089,0.00008964304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003722592,0.00004199683,0.982016,0.00001396932,0.00002071173,0.0002312574,0.00004901776,0.00015677,0.01052656,0.00002133612,0.0001343316,0.006415898],"study_design_scores_gemma":[0.00003246905,0.0002761981,0.989156,0.000007343281,0.00003552755,0.002497772,0.0001214735,0.001868438,0.005607518,0.0000528244,0.0003401594,0.000004220271],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9996061,0.00008591686,0.0001014246,0.00001421472,0.000002226322,0.000003453971,0.00004678289,0.000004558067,0.0001352419],"genre_scores_gemma":[0.999698,0.00001946352,0.0001420269,0.000008895598,0.000003306438,0.000002541476,0.00006164049,0.00000135202,0.0000627306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002011731,"threshold_uncertainty_score":0.006729841,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2810583998","doi":"10.1038/s41586-018-0291-z","title":"CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions","year":2018,"lang":"en","type":"article","venue":"Nature","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Institute for Advanced Research; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute; Medical Research Council; U.S. Department of Defense; European Commission; Prostate Cancer Foundation; Movember Foundation; Prostate Cancer UK; Canadian Institutes of Health Research; National Science Foundation; Cancer Research UK; Krembil Foundation; Stand Up To Cancer; Blood Cancer UK; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"DNA repair; Olaparib; CRISPR; Biology; PARP1; Poly ADP ribose polymerase; PARP inhibitor; Gene; Genome instability; Molecular biology; Polymerase; Cancer research; DNA damage; DNA; Genetics","authors":[{"name":"Michal Zimmermann","is_ca":true},{"name":"Olga Murina","is_ca":false},{"name":"Martin A.M. Reijns","is_ca":false},{"name":"Angelo Agathanggelou","is_ca":false},{"name":"Rachel Challis","is_ca":false},{"name":"Žygimantė Tarnauskaitė","is_ca":false},{"name":"Morwenna Muir","is_ca":false},{"name":"Adeline Fluteau","is_ca":false},{"name":"Michael Aregger","is_ca":true},{"name":"Andrea McEwan","is_ca":true},{"name":"Wei Yuan","is_ca":false},{"name":"Matthew Clarke","is_ca":false},{"name":"Maryou B. Lambros","is_ca":false},{"name":"Shankara Paneesha","is_ca":false},{"name":"Paul Moss","is_ca":false},{"name":"Megha Chandrashekhar","is_ca":true},{"name":"Stéphane Angers","is_ca":true},{"name":"Jason Moffat","is_ca":true},{"name":"Valerie G. Brunton","is_ca":false},{"name":"Traver Hart","is_ca":false},{"name":"Johann S. de Bono","is_ca":false},{"name":"Tatjana Stanković","is_ca":false},{"name":"Andrew P. Jackson","is_ca":false},{"name":"Daniel Durocher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02277558244706928,"gpt":0.3584049899763154,"spread":0.3356294075292461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004167107,0.000685938,0.0004994501,0.0004306952,0.000344124,0.000826666,0.0007251803,0.00134894,0.00474647],"category_scores_gemma":[0.0005488573,0.000432257,0.0004569529,0.0002525799,0.0004753753,0.000298598,0.0004400507,0.001379207,0.001244735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005087779,"about_ca_system_score_gemma":0.0002955471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005566966,"about_ca_topic_score_gemma":0.001472416,"domain_scores_codex":[0.9994718,0.00008399236,0.00004107887,0.0001369373,0.0002034189,0.0000627863],"domain_scores_gemma":[0.9995975,0.000173302,0.0000895209,0.00006642586,0.00002879016,0.00004451421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001123111,0.0000510648,0.0001570745,0.00007763859,0.00002887341,0.0002709615,0.00002174472,0.000514367,0.9928207,0.0009445476,0.0004084578,0.004592262],"study_design_scores_gemma":[0.00001708504,0.0001187478,0.000398264,0.000007020358,0.00003134909,0.0003037915,0.0000114949,0.001233869,0.9934915,0.0001946119,0.004183933,0.000008400865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7395165,0.004376758,0.1995056,0.001692933,0.0006316238,0.0005741194,0.004750921,0.006211314,0.04274011],"genre_scores_gemma":[0.9420106,0.001072631,0.04239079,0.0003856533,0.00002484229,0.0001246008,0.001295111,0.0003500076,0.01234583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00474647,"threshold_uncertainty_score":0.0158785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623263876","doi":"10.1158/2159-8290.cd-17-0419","title":"Secondary Somatic Mutations Restoring <i>RAD51C</i> and <i>RAD51D</i> Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":417,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Institute of General Medical Sciences; Cancer Research UK","keywords":"Cancer research; PARP inhibitor; Germline mutation; Biology; Olaparib; Mutation; Medicine; Genetics; Gene; Poly ADP ribose polymerase; Polymerase","authors":[{"name":"Olga Kondrashova","is_ca":false},{"name":"Minh Nguyen","is_ca":false},{"name":"Kristy Shield‐Artin","is_ca":false},{"name":"Anna V. Tinker","is_ca":true},{"name":"Nelson N.H. Teng","is_ca":false},{"name":"Maria I. Harrell","is_ca":false},{"name":"Michael J. Kuiper","is_ca":false},{"name":"Gwo‐Yaw Ho","is_ca":false},{"name":"Holly E. Barker","is_ca":false},{"name":"Maria Jasin","is_ca":false},{"name":"Rohit Prakash","is_ca":false},{"name":"Elizabeth M. Kass","is_ca":false},{"name":"Meghan R. Sullivan","is_ca":false},{"name":"Gregory J. Brunette","is_ca":false},{"name":"Kara A. Bernstein","is_ca":false},{"name":"Robert L. Coleman","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Ganessan Kichenadasse","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"James Sun","is_ca":false},{"name":"Liliane Robillard","is_ca":false},{"name":"Lara Maloney","is_ca":false},{"name":"David D.L. Bowtell","is_ca":false},{"name":"Heidi Giordano","is_ca":false},{"name":"Matthew J. Wakefield","is_ca":false},{"name":"Scott H. Kaufmann","is_ca":false},{"name":"Andrew D. Simmons","is_ca":false},{"name":"Thomas C. Harding","is_ca":false},{"name":"Mitch Raponi","is_ca":false},{"name":"Iain A. McNeish","is_ca":false},{"name":"Elizabeth M. Swisher","is_ca":false},{"name":"Kevin Lin","is_ca":false},{"name":"Clare L. Scott","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02426957560772021,"gpt":0.284101260368508,"spread":0.2598316847607878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001457284,0.0001532057,0.0002074671,0.0002808472,0.0001560349,0.0002495547,0.0001365037,0.0002920924,0.0008813525],"category_scores_gemma":[0.0002933007,0.0001254401,0.0002069429,0.000165627,0.0001738237,0.00006152943,0.0001143105,0.0003415737,0.0001479145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002616262,"about_ca_system_score_gemma":0.0001235542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007351713,"about_ca_topic_score_gemma":0.0009232651,"domain_scores_codex":[0.9998873,0.000019842,0.00001205751,0.00003171161,0.00002525691,0.00002382747],"domain_scores_gemma":[0.9997911,0.00003858649,0.00006265948,0.00002526146,0.00002982973,0.00005257706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001063121,0.0002040134,0.1185216,0.00005909189,0.00006018259,0.002954386,0.000109081,0.0005077415,0.8667519,0.00009081176,0.0002160366,0.00946215],"study_design_scores_gemma":[0.0001321123,0.002004626,0.6887446,0.00001125183,0.00009930508,0.02005725,0.0001386883,0.002832492,0.2843053,0.00008553189,0.001575325,0.00001360838],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994957,0.00008963386,0.0001620994,0.00001112453,0.000001638639,0.000009191758,0.00006882777,0.000007350904,0.0001543994],"genre_scores_gemma":[0.9995054,0.00002912768,0.0001888868,0.00001267828,0.000001515054,0.000004476324,0.0001221311,0.00000263573,0.0001330555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008813525,"threshold_uncertainty_score":0.002948403,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4236289131","doi":"10.1016/s1470-2045(21)00073-5","title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":416,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck; AstraZeneca","keywords":"Olaparib; Medicine; BRCA mutation; Internal medicine; Clinical endpoint; Ovarian cancer; Oncology; Placebo; Progression-free survival; PARP inhibitor; Randomized controlled trial; Cancer; Chemotherapy; Pathology","authors":[{"name":"Andrés Poveda","is_ca":false},{"name":"Anne Floquet","is_ca":false},{"name":"Jonathan A. Ledermann","is_ca":false},{"name":"Rebecca Asher","is_ca":false},{"name":"Richard T. Penson","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Jacob Korach","is_ca":false},{"name":"Tomasz Huzarski","is_ca":false},{"name":"Sandro Pignata","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Alessandra Baldoni","is_ca":false},{"name":"Tjoung-Won Park-Simon","is_ca":false},{"name":"Kenji Tamura","is_ca":false},{"name":"Gabe S. Sonke","is_ca":false},{"name":"Alla Lisyanskaya","is_ca":false},{"name":"Jae‐Hoon Kim","is_ca":false},{"name":"Elias Abdo Filho","is_ca":false},{"name":"Tsveta Milenkova","is_ca":false},{"name":"Elizabeth Lowe","is_ca":false},{"name":"Philip Rowe","is_ca":false},{"name":"Ignace Vergote","is_ca":false},{"name":"Éric Pujade-Lauraine","is_ca":false},{"name":"Tomasz Byrski","is_ca":false},{"name":"Patricia Pautier","is_ca":false},{"name":"Philipp Harter","is_ca":false},{"name":"Nicoletta Colombo","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Maria Ornella Nicoletto","is_ca":false},{"name":"Fiona Nussey","is_ca":false},{"name":"Andrew R. Clamp","is_ca":false},{"name":"A. Poveda Velasco","is_ca":false},{"name":"Manuel Rodrigues","is_ca":false},{"name":"Jean‐Pierre Lotz","is_ca":false},{"name":"Frédèric Selle","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Diane Provencher","is_ca":false},{"name":"Aleix Prat Aparicio","is_ca":false},{"name":"Laura Vidal Boixader","is_ca":false},{"name":"Clare L. Scott","is_ca":false},{"name":"Mayu Yunokawa","is_ca":false},{"name":"Jacques Médioni","is_ca":false},{"name":"Nicolas Pécuchet","is_ca":false},{"name":"Coraline Dubot","is_ca":false},{"name":"Thibault De La Motte Rouge","is_ca":false},{"name":"Marie‐Christine Kaminsky","is_ca":false},{"name":"B. Weber","is_ca":false},{"name":"Alain Lortholary","is_ca":false},{"name":"Christine Parkinson","is_ca":false},{"name":"Sarah Williams","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Jonathan A. Cosin","is_ca":false},{"name":"James Hoffman","is_ca":false},{"name":"Marie Plante","is_ca":false},{"name":"Allan Covens","is_ca":false},{"name":"Florence Joly","is_ca":false},{"name":"Holger W. Hirte","is_ca":false},{"name":"Amnon Amit","is_ca":true},{"name":"Koji Matsumoto","is_ca":false},{"name":"Sergei Tjulandin","is_ca":false},{"name":"Laurence Gladieff","is_ca":false},{"name":"Roberto Sabbatini","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Patrick Timmins","is_ca":false},{"name":"Daniel Kredentser","is_ca":false},{"name":"Nuria Laínez Milagro","is_ca":false},{"name":"M.P. Barretina Ginesta","is_ca":false},{"name":"Ariadna Tibau Martorell","is_ca":false},{"name":"Alfonso Gómez de Liaño","is_ca":false},{"name":"Belén Ojeda González","is_ca":false},{"name":"Linda Mileshkin","is_ca":false},{"name":"Masaki Mandai","is_ca":false},{"name":"Ingrid Boere","is_ca":false},{"name":"Petronella B. Ottevanger","is_ca":false},{"name":"Joo‐Hyun Nam","is_ca":false},{"name":"Salima Hamizi","is_ca":false},{"name":"Francesco Cognetti","is_ca":false},{"name":"David Warshal","is_ca":false},{"name":"Elizabeth Dickson-Michelson","is_ca":false},{"name":"Scott Kamelle","is_ca":false},{"name":"Nathalie D. McKenzie","is_ca":false},{"name":"Gustavo C. Rodriguez","is_ca":false},{"name":"Deborah K. Armstrong","is_ca":false},{"name":"Eva Chalas","is_ca":false},{"name":"Paul Celano","is_ca":false},{"name":"Kian Behbakht","is_ca":false},{"name":"Susan A. Davidson","is_ca":false},{"name":"Stephen Welch","is_ca":false},{"name":"Limor Helpman","is_ca":false},{"name":"Ami Fishman","is_ca":false},{"name":"Ilan Bruchim","is_ca":false},{"name":"Magdalena Sikorska","is_ca":false},{"name":"Anna Słowińska","is_ca":false},{"name":"Wojciech Rogowski","is_ca":false},{"name":"Mariusz Bidziński","is_ca":false},{"name":"Beata Śpiewankiewicz","is_ca":false},{"name":"César Mendiola Fernández","is_ca":false},{"name":"Martina Gropp‐Meier","is_ca":false},{"name":"Toshiaki Saito","is_ca":false},{"name":"Kazuhiro Takehara","is_ca":false},{"name":"Takayuki Enomoto","is_ca":false},{"name":"Hidemichi Watari","is_ca":false},{"name":"Chel Hun Choi","is_ca":false},{"name":"Byoung‐Gie Kim","is_ca":false},{"name":"Jae‐Weon Kim","is_ca":false},{"name":"Roberto Hegg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05218418572592092,"gpt":0.3670435714528127,"spread":0.3148593857268918,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001406134,0.001291867,0.003287844,0.0004174676,0.0003243285,0.001095934,0.0008902773,0.001550388,0.004666763],"category_scores_gemma":[0.001602662,0.0005918104,0.001825015,0.0004768669,0.0009539338,0.001303681,0.0003533113,0.002810608,0.0008294868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005189446,"about_ca_system_score_gemma":0.0006837313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006049051,"about_ca_topic_score_gemma":0.001442006,"domain_scores_codex":[0.9994628,0.0003021304,0.00003782546,0.00009825645,0.00003541151,0.00006371331],"domain_scores_gemma":[0.9991753,0.0003124985,0.0001654354,0.00006999048,0.00004165825,0.0002350922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9733479,0.001581118,0.0004424025,0.0007746596,0.0009077007,0.00004113584,0.00004888525,0.0002584227,0.002182692,0.00006914138,0.0005837756,0.01976222],"study_design_scores_gemma":[0.9626267,0.03402028,0.001538276,0.00004324348,0.0003888462,0.00005025823,0.00002130711,0.0003236893,0.0002741253,0.0001240438,0.0005714992,0.00001763116],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749531,0.01758634,0.000805132,0.0008432092,0.0005453394,0.001758812,0.001253369,0.0002145065,0.002040134],"genre_scores_gemma":[0.9871042,0.005775774,0.001193693,0.0009277305,0.0003161572,0.001158517,0.001135826,0.00003311098,0.002354912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004666763,"threshold_uncertainty_score":0.01561195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164708087","doi":"10.1093/nar/gkn771","title":"Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes","year":2008,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":415,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; University of Alberta","funders":"National Institute of Neurological Disorders and Stroke; U.S. Public Health Service; Canadian Institutes of Health Research; Centre National de la Recherche Scientifique","keywords":"Proteome; Biology; Poly ADP ribose polymerase; Biochemistry; Ribose; Proteomics; Plasma protein binding; In silico; Enzyme; Computational biology; Polymerase; Gene","authors":[{"name":"Jean-Philippe Gagné","is_ca":true},{"name":"Maxim Isabelle","is_ca":true},{"name":"Ken Sin Lo","is_ca":true},{"name":"Sylvie Bourassa","is_ca":true},{"name":"Michael J. Hendzel","is_ca":true},{"name":"Valina L. Dawson","is_ca":true},{"name":"Ted M. Dawson","is_ca":true},{"name":"Guy G. Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08688888882635037,"gpt":0.3708946421512399,"spread":0.2840057533248895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001894542,0.000299915,0.000307009,0.000433466,0.0002453304,0.0003651236,0.0001465502,0.0003055271,0.000374794],"category_scores_gemma":[0.0002691939,0.0001046288,0.0002439354,0.0004188362,0.0001433334,0.0002017465,0.0001833036,0.0002999627,0.0002142611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000162771,"about_ca_system_score_gemma":0.0001444796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003616523,"about_ca_topic_score_gemma":0.0005174769,"domain_scores_codex":[0.9998888,0.00002088639,0.000006737418,0.00003839401,0.00003265152,0.00001248027],"domain_scores_gemma":[0.9999092,0.00002179718,0.00002718759,0.000008972871,0.00001507114,0.00001782315],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003525133,0.00007204846,0.006676424,0.0001106344,0.00006422255,0.0002732257,0.00007087032,0.0008022458,0.9853044,0.0002485289,0.0003285012,0.005696388],"study_design_scores_gemma":[0.00006053573,0.0005418058,0.3080155,0.00003497404,0.000329323,0.003502958,0.0003534643,0.05337711,0.615557,0.001488614,0.01668944,0.00004933033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891951,0.002060346,0.006715132,0.0001392816,0.00001402658,0.00002295274,0.001155981,0.00007183847,0.0006253884],"genre_scores_gemma":[0.9845958,0.001226763,0.01008669,0.0000861268,0.00001187268,0.00002510698,0.003214709,0.00001741229,0.0007355012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000433466,"threshold_uncertainty_score":0.001253784,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992476369","doi":"10.1016/s0301-472x(03)00083-3","title":"PARP-1, a determinant of cell survival in response to DNA damage","year":2003,"lang":"en","type":"review","venue":"Experimental Hematology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Poly ADP ribose polymerase; DNA damage; DNA repair; Biology; Genome instability; DNA; Apoptosis; Polymerase; Cell biology; DNA replication; Cancer research; Genetics","authors":[{"name":"Véronique Bouchard","is_ca":true},{"name":"Michèle Rouleau","is_ca":true},{"name":"Guy G. Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06411873971903466,"gpt":0.4195844937348274,"spread":0.3554657540157927,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006075395,0.00114282,0.001947789,0.001130308,0.0003155127,0.001181565,0.001368258,0.001287458,0.002259222],"category_scores_gemma":[0.0005295872,0.0003126388,0.0003256245,0.001717914,0.0008652329,0.001266705,0.0004334003,0.002223548,0.002496953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00077243,"about_ca_system_score_gemma":0.0008316459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007633483,"about_ca_topic_score_gemma":0.001136275,"domain_scores_codex":[0.9998406,0.00001862788,0.0000216177,0.00004055996,0.00006383289,0.00001474997],"domain_scores_gemma":[0.9996955,0.0001226482,0.00005497131,0.0000128583,0.00008183971,0.00003214182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002329355,0.00009541121,0.0002635338,0.008234348,0.0000687726,0.0003035312,0.00004222307,0.0005242725,0.009990036,0.003196663,0.0257979,0.9512504],"study_design_scores_gemma":[0.00006991061,0.0002059684,0.001666208,0.001426883,0.0001621945,0.002413329,0.00008639982,0.0002060275,0.005779558,0.003424841,0.9845233,0.0000354029],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002586422,0.9972242,0.0004505596,0.0003035837,0.0002954697,0.000006566375,0.00002537205,0.0000161416,0.001419399],"genre_scores_gemma":[0.001212387,0.9970911,0.0003627677,0.0001793822,0.0002314166,0.000009866211,0.00004862117,0.000001748362,0.0008626716],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002259222,"threshold_uncertainty_score":0.007557869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281666355","doi":"10.1200/jco.22.01003","title":"A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Sherbrooke","funders":"National Cancer Institute; Genentech; Eisai; National Institute for Health and Care Research; MacroGenics; Clovis Oncology; NuCana; Novocure; Puma Biotechnology; Regeneron Pharmaceuticals; Array BioPharma; EMD Serono; Mersana Therapeutics; Karyopharm Therapeutics; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Amgen; Pfizer","keywords":"Medicine; Population; Hazard ratio; Internal medicine; Ovarian cancer; Clinical endpoint; Placebo; Oncology; BRCA mutation; Surgery; Cancer; Clinical trial; Confidence interval; Pathology","authors":[{"name":"Bradley J. Monk","is_ca":false},{"name":"Christine Parkinson","is_ca":false},{"name":"Myong Cheol Lim","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Ana Oaknin","is_ca":false},{"name":"Michelle Wilson","is_ca":false},{"name":"Robert L. Coleman","is_ca":false},{"name":"Domenica Lorusso","is_ca":false},{"name":"Paul Bessette","is_ca":true},{"name":"Sharad Ghamande","is_ca":false},{"name":"Athina Christopoulou","is_ca":false},{"name":"Diane Provencher","is_ca":true},{"name":"Emily Prendergast","is_ca":false},{"name":"Fuat Demirkıran","is_ca":false},{"name":"Olga Mikheeva","is_ca":false},{"name":"Oladapo Yeku","is_ca":false},{"name":"Anita Chudecka-Głaz","is_ca":false},{"name":"Michael Schenker","is_ca":false},{"name":"Ramey D. Littell","is_ca":false},{"name":"Tamar Safra","is_ca":false},{"name":"Hung‐Hsueh Chou","is_ca":false},{"name":"Mark A. Morgan","is_ca":false},{"name":"Vít Drochýtek","is_ca":false},{"name":"Joyce N. Barlin","is_ca":false},{"name":"Toon Van Gorp","is_ca":false},{"name":"Frederick R. Ueland","is_ca":false},{"name":"Gabriel Lindahl","is_ca":false},{"name":"Charles Anderson","is_ca":false},{"name":"Dearbhaile Catherine Collins","is_ca":false},{"name":"Kathleen N. Moore","is_ca":false},{"name":"Frederik Marmé","is_ca":false},{"name":"Shannon N. Westin","is_ca":false},{"name":"Iain A. McNeish","is_ca":false},{"name":"Danny Shih","is_ca":false},{"name":"Kevin K. Lin","is_ca":false},{"name":"Sandra Goble","is_ca":false},{"name":"Stephanie Hume","is_ca":false},{"name":"Keiichi Fujiwara","is_ca":false},{"name":"Rebecca Kristeleit","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1037382995368031,"gpt":0.4865092343933121,"spread":0.382770934856509,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001427334,0.001079041,0.001944009,0.0004478031,0.0002840055,0.0007027153,0.0008168307,0.001305842,0.005477828],"category_scores_gemma":[0.001471957,0.0004725293,0.0009102949,0.0003568412,0.0007952519,0.0006685262,0.0003471454,0.00193011,0.0008170043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006253335,"about_ca_system_score_gemma":0.0009424274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007347192,"about_ca_topic_score_gemma":0.002279593,"domain_scores_codex":[0.9994757,0.0003272741,0.00002055424,0.00008812697,0.00003177543,0.00005652149],"domain_scores_gemma":[0.9992412,0.0002095231,0.0001929812,0.00006843447,0.00004498197,0.0002428069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9683542,0.006667632,0.0006902568,0.0003080088,0.0005242391,0.00002957422,0.00003258834,0.0003163305,0.002929226,0.0001322347,0.001077699,0.01893811],"study_design_scores_gemma":[0.9351439,0.06217625,0.001254852,0.00001505277,0.0001817544,0.00002996605,0.000008939724,0.0003075942,0.0002234102,0.00008809193,0.0005636531,0.000006479649],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825545,0.004791573,0.0007946767,0.00068377,0.0005078246,0.005964679,0.001446897,0.000137929,0.003118119],"genre_scores_gemma":[0.9798189,0.002217974,0.002383551,0.001541472,0.0005909142,0.007367109,0.002120057,0.00002508667,0.003934898],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005477828,"threshold_uncertainty_score":0.01832509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3208204329","doi":"10.1016/s1470-2045(21)00531-3","title":"Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; AstraZeneca","keywords":"Olaparib; Ovarian cancer; Mutation; BRCA mutation; Clinical trial; Cancer","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04020537618833177,"gpt":0.3627496910676291,"spread":0.3225443148792974,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002066207,0.001646015,0.003701641,0.0004210163,0.0004827471,0.001298916,0.001041427,0.002004996,0.00463624],"category_scores_gemma":[0.001743863,0.0006294756,0.002743182,0.0004785932,0.001240505,0.001489094,0.0004747766,0.003347686,0.0009892314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008135705,"about_ca_system_score_gemma":0.0008681882,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001000418,"about_ca_topic_score_gemma":0.001918931,"domain_scores_codex":[0.9992921,0.0003454009,0.00003654573,0.0001455779,0.00005088628,0.0001294349],"domain_scores_gemma":[0.9987789,0.0003199797,0.0003047273,0.0001331179,0.00005933442,0.0004040481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9826201,0.001748991,0.0007624234,0.0003056918,0.0009559313,0.00003183231,0.0000334848,0.0002491619,0.001229576,0.00004432932,0.0004879801,0.01153036],"study_design_scores_gemma":[0.9501166,0.04422098,0.003700906,0.00003454239,0.0005910416,0.00004738449,0.00002181101,0.0003339581,0.0002194901,0.0001613604,0.0005344499,0.00001749844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842601,0.00923807,0.0006554594,0.0007589425,0.0004529094,0.001353387,0.001420966,0.0001443981,0.001715793],"genre_scores_gemma":[0.9886006,0.003366562,0.0007999042,0.001141348,0.0003764794,0.001380453,0.001989464,0.00002610756,0.002319107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00463624,"threshold_uncertainty_score":0.01550972,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975272351","doi":"10.1016/j.molcel.2008.08.009","title":"Substrate-Assisted Catalysis by PARP10 Limits Its Activity to Mono-ADP-Ribosylation","year":2008,"lang":"en","type":"article","venue":"Molecular Cell","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":353,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Polymerase; Biology; ADP-ribosylation; Poly ADP ribose polymerase; Biochemistry; Transferase; Enzyme; Residue (chemistry); PARP1; DNA repair; DNA; NAD+ kinase","authors":[{"name":"H. O. Kleine","is_ca":false},{"name":"Elżbieta Poręba","is_ca":false},{"name":"Krzysztof Leśniewicz","is_ca":false},{"name":"Paul O. Hassa","is_ca":false},{"name":"Michael O. Hottiger","is_ca":false},{"name":"David W. Litchfield","is_ca":true},{"name":"Brian H. Shilton","is_ca":true},{"name":"Bernhard Lüscher","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03108811992052445,"gpt":0.2788114898314135,"spread":0.247723369910889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006014555,0.0005303674,0.0004831114,0.0001433354,0.0002275451,0.001231337,0.0007028027,0.0006884608,0.00554767],"category_scores_gemma":[0.0006852621,0.0003465427,0.0003294337,0.0001750801,0.0003915812,0.0006739293,0.0004891966,0.001341958,0.003173989],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003698124,"about_ca_system_score_gemma":0.0003943334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003521654,"about_ca_topic_score_gemma":0.0003670095,"domain_scores_codex":[0.9994627,0.0001023234,0.0000364643,0.0001488976,0.0001144941,0.0001352052],"domain_scores_gemma":[0.9994661,0.0001618442,0.00008860927,0.0001091791,0.00008061951,0.00009360593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007590024,0.0001939346,0.001397616,0.000168873,0.00003991003,0.0002211715,0.00005034022,0.0006481769,0.9751424,0.001122235,0.001494441,0.01876188],"study_design_scores_gemma":[0.0000206961,0.0004028817,0.0007190168,0.000007826088,0.000008430965,0.000378815,0.00003169572,0.001536475,0.9914284,0.0002181838,0.005239199,0.000008399378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.96319,0.005519325,0.01608756,0.0008783984,0.000360712,0.00006016323,0.0007790718,0.0005318029,0.0125929],"genre_scores_gemma":[0.9917564,0.0008758251,0.00205311,0.000194175,0.00002093449,0.00002241353,0.0007507915,0.00005461554,0.004271778],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00554767,"threshold_uncertainty_score":0.0185588,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2888493183","doi":"10.1016/j.dnarep.2018.08.022","title":"The comings and goings of PARP-1 in response to DNA damage","year":2018,"lang":"en","type":"review","venue":"DNA repair","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Poly ADP ribose polymerase; Biology; DNA damage; DNA repair; Chromatin; DNA; Polymerase; Cell biology; Genetics","authors":[{"name":"John M. Pascal","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04573360199352177,"gpt":0.3756352712475349,"spread":0.3299016692540131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006996942,0.0006478862,0.001157316,0.001218606,0.0002877407,0.001532689,0.0009546416,0.001199576,0.003446779],"category_scores_gemma":[0.001013112,0.0002897293,0.0004888724,0.001216805,0.0007027019,0.002112473,0.0007433926,0.002653641,0.001328115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005540018,"about_ca_system_score_gemma":0.0009287153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007009209,"about_ca_topic_score_gemma":0.001503733,"domain_scores_codex":[0.9997577,0.00004509097,0.00003589491,0.00004501527,0.00008520071,0.00003113119],"domain_scores_gemma":[0.999669,0.0001414718,0.00005903566,0.00001439982,0.00008627008,0.00002990558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001359407,0.00004676532,0.0002478999,0.01432762,0.0001004427,0.0002472675,0.0001119409,0.0004349052,0.002517362,0.006573932,0.03115928,0.9440966],"study_design_scores_gemma":[0.00001619663,0.00009990075,0.0006780077,0.002489463,0.00009745198,0.0009629243,0.0001022154,0.00009930479,0.0009078613,0.003743659,0.9907826,0.00002057834],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009998954,0.9982721,0.000115855,0.0005057705,0.0002302991,0.000002795536,0.00001587157,0.000005816666,0.0007516267],"genre_scores_gemma":[0.0008772719,0.9981149,0.0001055814,0.0002229468,0.0002286377,0.00000294582,0.00001706619,0.000001110316,0.000429543],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003446779,"threshold_uncertainty_score":0.01153064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085908746","doi":"10.1038/sj.cdd.4400851","title":"Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases","year":2001,"lang":"en","type":"article","venue":"Cell Death and Differentiation","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":338,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Medical Research Council; Natural Sciences and Engineering Research Council of Canada","keywords":"Poly ADP ribose polymerase; Proteases; Caspase; Jurkat cells; Cathepsin; Cleavage (geology); Apoptosis; Molecular biology; Biology; Programmed cell death; Cytosol; Biochemistry; Polymerase; Cell biology; Enzyme; T cell; Genetics","authors":[{"name":"Stéphane Gobeil","is_ca":true},{"name":"Claudia Boucher","is_ca":true},{"name":"D. Nadeau","is_ca":true},{"name":"Guy G. Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01573362775224625,"gpt":0.2491917566021433,"spread":0.2334581288498971,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002858611,0.0002543142,0.0002681771,0.0003069762,0.0001775134,0.0003932352,0.0002534015,0.0004161994,0.001646757],"category_scores_gemma":[0.0004364557,0.0001595826,0.0003503349,0.0002430124,0.0002325156,0.0005201607,0.0001326747,0.0006471669,0.0006111728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003428952,"about_ca_system_score_gemma":0.000213026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000230618,"about_ca_topic_score_gemma":0.0002120287,"domain_scores_codex":[0.9998481,0.00002177836,0.00001556557,0.00002786305,0.00003901695,0.00004765149],"domain_scores_gemma":[0.9996994,0.00009509077,0.00006057402,0.00004279856,0.00004669152,0.00005547532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003222864,0.00004773004,0.000351246,0.00003709552,0.000009161073,0.0001335211,0.000015535,0.00008724205,0.9977382,0.0002126424,0.00003200155,0.001013224],"study_design_scores_gemma":[0.00002875454,0.0002634206,0.005546964,0.000005900969,0.00001677929,0.000969532,0.00002938107,0.0009330218,0.9907409,0.0001823983,0.001278319,0.000004739808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799843,0.003582878,0.01222612,0.0001787747,0.0000404677,0.0000677435,0.001084873,0.00003774243,0.002797158],"genre_scores_gemma":[0.9890338,0.001337826,0.004567531,0.0001076349,0.00001653166,0.00004458799,0.002294309,0.00002107785,0.002576654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001646757,"threshold_uncertainty_score":0.005508959,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997953313","doi":"10.1073/pnas.0406182101","title":"Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality","year":2004,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Poly ADP ribose polymerase; Biology; Embryonic stem cell; DNA damage; Synthetic lethality; Cytotoxicity; DNA repair; Cell biology; Molecular biology; Biochemistry; Polymerase; Enzyme; DNA; In vitro; Gene","authors":[{"name":"David W. Koh","is_ca":true},{"name":"Ann M. Lawler","is_ca":true},{"name":"Marc F. Poitras","is_ca":true},{"name":"Masayuki Sasaki","is_ca":true},{"name":"Sigrid Wattler","is_ca":true},{"name":"Michael Nehls","is_ca":true},{"name":"Tobias Stöger","is_ca":true},{"name":"Guy G. Poirier","is_ca":true},{"name":"Valina L. Dawson","is_ca":true},{"name":"Ted M. Dawson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04450856181625495,"gpt":0.3339432891514686,"spread":0.2894347273352137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001272871,0.0003445799,0.0002670094,0.0001782103,0.00009790614,0.0002448257,0.0001882619,0.0002925676,0.0008040058],"category_scores_gemma":[0.000132642,0.0001392939,0.0002073109,0.0001264125,0.0002418428,0.0001373284,0.0002279711,0.0005197332,0.0003417696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001751814,"about_ca_system_score_gemma":0.0001065824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002844529,"about_ca_topic_score_gemma":0.0004775355,"domain_scores_codex":[0.9998294,0.00003438421,0.00002289146,0.00003949635,0.00004735139,0.00002648243],"domain_scores_gemma":[0.999786,0.00004936881,0.0000831304,0.00003238659,0.00001014896,0.00003904631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003645439,0.000007919066,0.0001828081,0.00001105088,0.000004479946,0.00007124801,0.000003981072,0.00003831801,0.9989177,0.00002958866,0.00001483722,0.0006816214],"study_design_scores_gemma":[0.000006286549,0.0002946711,0.004912566,0.000002996636,0.00001133159,0.0008037338,0.00001173232,0.0003089962,0.9921756,0.00002523229,0.001444004,0.000002895255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927139,0.001610658,0.004217756,0.0001214244,0.00002232616,0.00001894037,0.0003812157,0.00007768163,0.0008360592],"genre_scores_gemma":[0.9937111,0.001171258,0.002544479,0.00005885027,0.00000649931,0.00002489507,0.0006378479,0.0000261693,0.00181897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008040058,"threshold_uncertainty_score":0.00268966,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3014627414","doi":"10.1126/science.aax6367","title":"Structural basis for allosteric PARP-1 retention on DNA breaks","year":2020,"lang":"en","type":"article","venue":"Science","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":331,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Université de Montréal","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health; Cancer Research UK; National Cancer Institute; Breast Cancer Now","keywords":"Poly ADP ribose polymerase; Allosteric regulation; DNA; DNA repair; Polymerase; Chemistry; DNA damage; PARP inhibitor; Computational biology; Cancer research; Biochemistry; Biology; Enzyme","authors":[{"name":"Levani Zandarashvili","is_ca":false},{"name":"Marie-France Langelier","is_ca":true},{"name":"Uday Kiran Velagapudi","is_ca":false},{"name":"Mark A. Hancock","is_ca":true},{"name":"Jamin D. Steffen","is_ca":false},{"name":"Ramya Billur","is_ca":false},{"name":"Zain M. Hannan","is_ca":false},{"name":"Andrew J. Wicks","is_ca":false},{"name":"Dragomir B. Krastev","is_ca":false},{"name":"Stephen J. Pettitt","is_ca":false},{"name":"Christopher J. Lord","is_ca":false},{"name":"Tanaji T. Talele","is_ca":false},{"name":"John M. Pascal","is_ca":true},{"name":"Ben E. Black","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0836537283378432,"gpt":0.340849481369791,"spread":0.2571957530319479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001599539,0.0002177333,0.0001836194,0.00008611652,0.0003137217,0.0003303023,0.0007428586,0.0004710017,0.00502034],"category_scores_gemma":[0.0001863608,0.0001666898,0.00018657,0.00005713673,0.0004545464,0.0003769524,0.0003323444,0.001004027,0.000740717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003269213,"about_ca_system_score_gemma":0.0002563709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001579493,"about_ca_topic_score_gemma":0.0002434096,"domain_scores_codex":[0.9999086,0.00001015234,0.00000546214,0.00002849787,0.00002143314,0.00002579356],"domain_scores_gemma":[0.9999083,0.0000179393,0.00003196819,0.00001045405,0.000008792452,0.00002249644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005743437,0.0002462521,0.0004745809,0.0002450507,0.000025404,0.0004353558,0.00007673077,0.003266466,0.9645358,0.01920856,0.001199874,0.009711671],"study_design_scores_gemma":[0.000385278,0.003037014,0.002250197,0.00004227734,0.00004414739,0.0009793718,0.00007275273,0.009142187,0.955418,0.004318155,0.02427033,0.00004027781],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9346761,0.005250175,0.02233267,0.001933841,0.0004197948,0.0001807695,0.0003583532,0.0005547706,0.03429364],"genre_scores_gemma":[0.994372,0.0008151904,0.001631848,0.0003999888,0.00002467859,0.00004141606,0.0001336232,0.00001937597,0.00256186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00502034,"threshold_uncertainty_score":0.01679474,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3183970717","doi":"10.1111/febs.16142","title":"ADP‐ribosyltransferases, an update on function and nomenclature","year":2021,"lang":"en","type":"article","venue":"FEBS Journal","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Institute of Cancer Research; Université Laval","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; Cancer Research UK; National Institutes of Health; RWTH Aachen University; Deutsche Forschungsgemeinschaft; Wellcome Trust","keywords":"Nomenclature; Function (biology); Computational biology; Chemistry; Biology; Genetics; Zoology; Taxonomy (biology)","authors":[{"name":"Bernhard Lüscher","is_ca":false},{"name":"Ivan Ahel","is_ca":false},{"name":"Matthias Altmeyer","is_ca":false},{"name":"Alan Ashworth","is_ca":false},{"name":"Péter Bai","is_ca":false},{"name":"Paul Chang","is_ca":false},{"name":"Michael S. Cohen","is_ca":false},{"name":"Daniela Corda","is_ca":false},{"name":"Françoise Dantzer","is_ca":false},{"name":"Matthew D. Daugherty","is_ca":false},{"name":"Ted M. Dawson","is_ca":false},{"name":"Valina L. Dawson","is_ca":false},{"name":"Sebastian Deindl","is_ca":false},{"name":"Anthony R. Fehr","is_ca":false},{"name":"Karla L. H. Feijs","is_ca":false},{"name":"Dmitri V. Filippov","is_ca":false},{"name":"Jean‐Philippe Gagné","is_ca":true},{"name":"Giovanna Grimaldi","is_ca":false},{"name":"Sebastian Guettler","is_ca":true},{"name":"Nícolas C. Hoch","is_ca":false},{"name":"Michael O. Hottiger","is_ca":false},{"name":"Patricia Korn","is_ca":false},{"name":"W. Lee Kraus","is_ca":false},{"name":"Andreas G. Ladurner","is_ca":false},{"name":"L. Lehtiö","is_ca":false},{"name":"Anthony K. L. Leung","is_ca":false},{"name":"Christopher J. Lord","is_ca":false},{"name":"Aswin Mangerich","is_ca":false},{"name":"Ivan Matić","is_ca":false},{"name":"Jason Matthews","is_ca":false},{"name":"George‐Lucian Moldovan","is_ca":false},{"name":"Joel Moss","is_ca":false},{"name":"Gioacchino Natoli","is_ca":false},{"name":"Michael L. Nielsen","is_ca":false},{"name":"Mario Niepel","is_ca":false},{"name":"F. Nolte","is_ca":false},{"name":"John M. Pascal","is_ca":true},{"name":"Bryce M. Paschal","is_ca":false},{"name":"Krzysztof Pawłowski","is_ca":false},{"name":"Guy G. Poirier","is_ca":true},{"name":"Susan Smith","is_ca":false},{"name":"Gyula Timinszky","is_ca":false},{"name":"Zhao‐Qi Wang","is_ca":false},{"name":"José Yélamos","is_ca":false},{"name":"Xiaochun Yu","is_ca":false},{"name":"Roko Žaja","is_ca":false},{"name":"Mathias Ziegler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02064099260354682,"gpt":0.2970770958095009,"spread":0.2764361032059541,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001886416,0.001747183,0.001967628,0.003818827,0.0008719417,0.003522384,0.002431338,0.002219877,0.005186644],"category_scores_gemma":[0.002423828,0.0006264342,0.0010071,0.004980367,0.001855297,0.005201587,0.001517454,0.004697536,0.006852034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001859171,"about_ca_system_score_gemma":0.002757759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00155827,"about_ca_topic_score_gemma":0.001627451,"domain_scores_codex":[0.9988391,0.0001979443,0.0002830031,0.0002751315,0.0002976635,0.0001071461],"domain_scores_gemma":[0.9987105,0.0003520112,0.0001907515,0.000109082,0.0004836202,0.0001540886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003074567,0.0001448703,0.0007998708,0.007841228,0.0001283661,0.0008190805,0.0005826697,0.001030186,0.01858502,0.07104245,0.2288866,0.6698322],"study_design_scores_gemma":[0.000002613276,0.00002611606,0.00009776944,0.0002284565,0.00001711521,0.00045482,0.00002322228,0.00005357185,0.0006708982,0.003206672,0.9952073,0.000011513],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007590692,0.9633468,0.01112128,0.003507451,0.01075453,0.00004098309,0.000537536,0.0002372025,0.009695084],"genre_scores_gemma":[0.004933781,0.9524317,0.01693758,0.003830662,0.007475308,0.0001371538,0.002454039,0.0001790227,0.01162075],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005186644,"threshold_uncertainty_score":0.01735109,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993972255","doi":"10.1006/excr.2001.5263","title":"Importance of Poly(ADP-Ribose) Glycohydrolase in the Control of Poly(ADP-Ribose) Metabolism","year":2001,"lang":"en","type":"review","venue":"Experimental Cell Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Poly ADP ribose polymerase; Biology; Polymerase; Biochemistry; Ribose; Enzyme; ADP-ribosylation; DNA repair; RNA polymerase III; DNA; Chromatin; Cytoplasm; Cell biology; NAD+ kinase","authors":[{"name":"Laëtitia Davidovic","is_ca":false},{"name":"Momchil D. Vodenicharov","is_ca":true},{"name":"El Bachir Affar","is_ca":true},{"name":"Guy G. Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.126349552235156,"gpt":0.4686902832341981,"spread":0.3423407309990421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009017435,0.001276585,0.001949394,0.001401561,0.0004082021,0.001594689,0.001481832,0.001636363,0.002438151],"category_scores_gemma":[0.0005539997,0.0004015539,0.000401279,0.00256391,0.0008917133,0.002047278,0.0006025709,0.002568326,0.002980842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001081755,"about_ca_system_score_gemma":0.001213785,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001097911,"about_ca_topic_score_gemma":0.001607252,"domain_scores_codex":[0.9998099,0.00002512739,0.00002913883,0.00004394946,0.00007211593,0.00001987929],"domain_scores_gemma":[0.9996295,0.0001579159,0.00005363157,0.00001715272,0.00009936584,0.00004240236],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002797636,0.00009986939,0.0001699071,0.01042489,0.000081879,0.0005834886,0.000053071,0.0008866948,0.009552849,0.005122396,0.01770833,0.9550368],"study_design_scores_gemma":[0.00006070216,0.0001384017,0.0006420587,0.001126182,0.0001019918,0.001669583,0.00007224872,0.0001874352,0.003793645,0.002923551,0.9892557,0.0000285234],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002196764,0.9973792,0.0005948989,0.0003123676,0.0003404539,0.000006427552,0.00001536677,0.0000109875,0.001120577],"genre_scores_gemma":[0.0008493863,0.9978411,0.0004342852,0.0001227293,0.0001452832,0.00000495625,0.00003270741,0.000001086786,0.0005684114],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002438151,"threshold_uncertainty_score":0.008156478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3081315565","doi":"10.1016/s1470-2045(20)30447-2","title":"Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":321,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; AstraZeneca; Invitae; PharmaMar; Eisai; Pfizer","keywords":"Veliparib; Carboplatin; Oncology; Medicine; Placebo; Breast cancer; Internal medicine; BRCA mutation; Paclitaxel; Cancer; Chemotherapy; Biology; Genetics; Alternative medicine; Poly ADP ribose polymerase; Cisplatin; Pathology","authors":[{"name":"Véronique Dièras","is_ca":false},{"name":"Hyo S. Han","is_ca":false},{"name":"Bella Kaufman","is_ca":false},{"name":"Hans Wildiers","is_ca":false},{"name":"Michael Friedländer","is_ca":false},{"name":"Jean-Pierre Ayoub","is_ca":true},{"name":"Shannon L. Puhalla","is_ca":false},{"name":"Igor Bondarenko","is_ca":false},{"name":"Mario Campone","is_ca":false},{"name":"Erik Jakobsen","is_ca":false},{"name":"Mathilde Jalving","is_ca":false},{"name":"Cristina Oprean","is_ca":false},{"name":"Markéta Palácová","is_ca":false},{"name":"Yeon Hee Park","is_ca":false},{"name":"Yaroslav Shparyk","is_ca":false},{"name":"Eduardo Yáñez","is_ca":false},{"name":"Nikhil Khandelwal","is_ca":false},{"name":"Madan G. Kundu","is_ca":false},{"name":"Matthew W. Dudley","is_ca":false},{"name":"Christine K. Ratajczak","is_ca":false},{"name":"David Maag","is_ca":false},{"name":"Banu Arun","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07829391178294297,"gpt":0.3971052690556947,"spread":0.3188113572727517,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001654523,0.001973495,0.003197133,0.0004399658,0.0005126193,0.001487806,0.001183789,0.002311567,0.009383349],"category_scores_gemma":[0.001597789,0.0007900677,0.002528108,0.0005803425,0.001258778,0.001227451,0.0004817037,0.004314199,0.00168195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001013354,"about_ca_system_score_gemma":0.001100402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0016588,"about_ca_topic_score_gemma":0.003452639,"domain_scores_codex":[0.9994254,0.0002608319,0.00002871211,0.0001251497,0.00004056028,0.0001193836],"domain_scores_gemma":[0.9993842,0.0001803266,0.000136848,0.00005780456,0.00003493245,0.0002059438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.985104,0.002000474,0.0001565642,0.0006134007,0.0008735593,0.00002817953,0.00003022802,0.0002539576,0.001358237,0.0001199682,0.001024986,0.008436336],"study_design_scores_gemma":[0.9863434,0.01219937,0.0004156991,0.00002398353,0.0002141591,0.00001863094,0.000009815364,0.0001362126,0.0001074296,0.0001067957,0.0004154175,0.000009117639],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9618255,0.01512365,0.001494193,0.002056065,0.001490241,0.007901863,0.003863776,0.0004745638,0.005770176],"genre_scores_gemma":[0.969234,0.007888721,0.002134555,0.002749688,0.0006033727,0.007032774,0.002678137,0.00008196157,0.007596899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009383349,"threshold_uncertainty_score":0.03139043,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2095061901","doi":"10.1073/pnas.1405158111","title":"Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis","year":2014,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Drug Abuse; Canadian Institutes of Health Research","keywords":"Poly ADP ribose polymerase; NAD+ kinase; Hexokinase; Glycolysis; Programmed cell death; Polymerase; Ribose; Cell biology; Bioenergetics; Biology; Enzyme; Biochemistry; Chemistry; Mitochondrion; Apoptosis","authors":[{"name":"Shaida A. Andrabi","is_ca":false},{"name":"George K. E. Umanah","is_ca":false},{"name":"Calvin Chang","is_ca":false},{"name":"Daniel A. Stevens","is_ca":false},{"name":"Senthilkumar S. Karuppagounder","is_ca":false},{"name":"Jean-Philippe Gagné","is_ca":true},{"name":"Guy G. Poirier","is_ca":true},{"name":"Valina L. Dawson","is_ca":false},{"name":"Ted M. Dawson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03861303175714018,"gpt":0.3213103621072992,"spread":0.282697330350159,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009166534,0.0002922057,0.0002536483,0.0001251812,0.0001022995,0.0003541111,0.0002179807,0.0001689178,0.0007490944],"category_scores_gemma":[0.00009226905,0.0001549237,0.000211704,0.0001227656,0.0001740116,0.0002642477,0.0001732337,0.00039701,0.0003041298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003345537,"about_ca_system_score_gemma":0.0001683375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003043837,"about_ca_topic_score_gemma":0.0003752146,"domain_scores_codex":[0.9998564,0.00001722448,0.00001618268,0.0000450999,0.0000309249,0.00003416972],"domain_scores_gemma":[0.9999263,0.000008176814,0.00003072806,0.00001470966,0.000005680905,0.00001426101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001782192,0.00002239265,0.0003581106,0.00006811547,0.00001072343,0.00008218089,0.000009480351,0.0001011566,0.9954478,0.0004293333,0.00008061457,0.00321188],"study_design_scores_gemma":[0.00001358756,0.0002080063,0.007385197,0.000007254499,0.00001525091,0.0003883592,0.00001064117,0.0009558011,0.986924,0.0001731169,0.003915402,0.000003413003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.964994,0.008852622,0.02062162,0.0002057101,0.0001034557,0.00007924889,0.0005528295,0.0005223906,0.00406819],"genre_scores_gemma":[0.9919601,0.003014941,0.002649156,0.00004440226,0.00001098486,0.00004036407,0.0003619039,0.00001404051,0.001904018],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007490944,"threshold_uncertainty_score":0.002505898,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079891276","doi":"10.1016/j.molcel.2010.12.006","title":"PARP-3 and APLF Function Together to Accelerate Nonhomologous End-Joining","year":2011,"lang":"en","type":"article","venue":"Molecular Cell","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":311,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Biotechnology and Biological Sciences Research Council; Cancer Research UK","keywords":"DNA ligase; Biology; DNA repair protein XRCC4; Non-homologous end joining; DNA repair; Ku80; Chromatin; DNA; Molecular biology; Poly ADP ribose polymerase; Sticky and blunt ends; Genetics; Cell biology; DNA-binding protein; DNA mismatch repair; Polymerase; Gene; Transcription factor","authors":[{"name":"Stuart L. Rulten","is_ca":false},{"name":"Anna E.O. Fisher","is_ca":false},{"name":"Isabelle Robert","is_ca":false},{"name":"Maria C. Zuma","is_ca":false},{"name":"Michèle Rouleau","is_ca":true},{"name":"Limei Ju","is_ca":false},{"name":"Guy G. Poirier","is_ca":true},{"name":"Bernardo Reina‐San‐Martin","is_ca":false},{"name":"Keith W. Caldecott","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03390383084429662,"gpt":0.2578351082772855,"spread":0.2239312774329888,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007419187,0.0006930045,0.000547068,0.0007933816,0.000574301,0.001287453,0.0006770923,0.0009207135,0.008144545],"category_scores_gemma":[0.0007589333,0.0004166444,0.0008855901,0.0002763201,0.0003672498,0.001014355,0.0007108085,0.002449093,0.002827555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006347815,"about_ca_system_score_gemma":0.0004583101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002506084,"about_ca_topic_score_gemma":0.0002450702,"domain_scores_codex":[0.9995559,0.00006916341,0.00003423537,0.0001074022,0.0001082111,0.0001251788],"domain_scores_gemma":[0.9995583,0.0001209352,0.00008961185,0.00009045441,0.00005867833,0.00008205878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000827396,0.0002916336,0.001425671,0.0001791534,0.00007504521,0.0004984852,0.0000492197,0.001149004,0.9621727,0.002852247,0.001732961,0.0287465],"study_design_scores_gemma":[0.0001042338,0.000365495,0.00299738,0.000006918326,0.00002583461,0.001073884,0.00003539696,0.001981093,0.9766558,0.001210134,0.01553095,0.00001287635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8424481,0.02285332,0.1013104,0.003193893,0.001466586,0.0003935247,0.001774585,0.003369713,0.0231899],"genre_scores_gemma":[0.9743998,0.001912888,0.01095491,0.0004041947,0.0001139862,0.00008075823,0.001197961,0.0001119552,0.01082351],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008144545,"threshold_uncertainty_score":0.02724624,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1959879209","doi":"10.1242/jcs.114.20.3771","title":"Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis","year":2001,"lang":"en","type":"article","venue":"Journal of Cell Science","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Poly ADP ribose polymerase; Biology; Apoptosis; DNA damage; Polymerase; Proteases; PARP1; NAD+ kinase; Caspase; DNA; DNA repair; Molecular biology; Programmed cell death; Cell biology; Biochemistry; Enzyme","authors":[{"name":"Damien D’Amours","is_ca":false},{"name":"Frédéric R. Sallmann","is_ca":false},{"name":"Vishva M. Dixit","is_ca":false},{"name":"Guy G. Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02564871356309783,"gpt":0.3188024015278726,"spread":0.2931536879647748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001700627,0.0004013305,0.0002763908,0.0001642713,0.0001051169,0.0003888562,0.0002958183,0.0004501943,0.0008845204],"category_scores_gemma":[0.0001738015,0.0001039897,0.0003069203,0.0001068434,0.0003511832,0.0003516063,0.0001633989,0.0008728743,0.0002728852],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003312429,"about_ca_system_score_gemma":0.0001557682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000128487,"about_ca_topic_score_gemma":0.0001289481,"domain_scores_codex":[0.9998757,0.00001889448,0.00001796189,0.0000250368,0.00003259229,0.00002989001],"domain_scores_gemma":[0.9998196,0.00004666103,0.00005051269,0.00002376284,0.00001280529,0.00004672515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00008117034,0.00001904458,0.00009222011,0.00002064965,0.000002189376,0.00006507538,0.000003342114,0.00003990236,0.9990401,0.00009633545,0.000006991714,0.0005329755],"study_design_scores_gemma":[0.00002032428,0.0002037673,0.003578089,0.000005059114,0.00001146268,0.0007900172,0.00001524296,0.0009041522,0.9935471,0.0001381887,0.0007812773,0.000005191045],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905218,0.003872446,0.004297389,0.0002703996,0.00004024528,0.00002230029,0.0002577859,0.00008181851,0.000635882],"genre_scores_gemma":[0.9953513,0.001534559,0.001949748,0.00005481513,0.00001210184,0.00001613464,0.0002857599,0.00001216957,0.0007834331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008845204,"threshold_uncertainty_score":0.002959073,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2751912349","doi":"10.1016/j.ygyno.2017.08.022","title":"Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; University Health Network; Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research; Cancer Research UK; Clovis Oncology","keywords":"Medicine; Germline; Germline mutation; Somatic cell; PARP inhibitor; Poly ADP ribose polymerase; Ovarian carcinoma; Cancer research; Ovarian cancer; Mutation; Oncology; Polymerase; Internal medicine; Cancer; Genetics; Biology; DNA; Gene","authors":[{"name":"Amit M. Oza","is_ca":true},{"name":"Anna V. Tinker","is_ca":true},{"name":"Ana Oaknin","is_ca":false},{"name":"Ronnie Shapira‐Frommer","is_ca":false},{"name":"Iain A. McNeish","is_ca":false},{"name":"Elizabeth M. Swisher","is_ca":false},{"name":"Isabelle Ray‐Coquard","is_ca":false},{"name":"Katherine M. Bell‐McGuinn","is_ca":false},{"name":"Robert L. Coleman","is_ca":false},{"name":"David M. O’Malley","is_ca":false},{"name":"Alexandra Léary","is_ca":false},{"name":"Lee-may Chen","is_ca":false},{"name":"Diane Provencher","is_ca":true},{"name":"Ling Ma","is_ca":false},{"name":"James D. Brenton","is_ca":false},{"name":"Gottfried E. Konecny","is_ca":false},{"name":"Cesar M. Castro","is_ca":false},{"name":"Heidi Giordano","is_ca":false},{"name":"Lara Maloney","is_ca":false},{"name":"Sandra Goble","is_ca":false},{"name":"Kevin K. Lin","is_ca":false},{"name":"James Sun","is_ca":false},{"name":"Mitch Raponi","is_ca":false},{"name":"Lindsey Rolfe","is_ca":false},{"name":"Rebecca Kristeleit","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05371604839042909,"gpt":0.3439074718825645,"spread":0.2901914234921354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004956257,0.0003279033,0.0009656891,0.0005143738,0.0001072437,0.0006844104,0.0004291111,0.0003369557,0.0007004006],"category_scores_gemma":[0.002345934,0.0002285062,0.001038522,0.0006541163,0.0002770255,0.0004160709,0.0003871768,0.0006629937,0.0001091162],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005907822,"about_ca_system_score_gemma":0.0006081191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005590445,"about_ca_topic_score_gemma":0.001709036,"domain_scores_codex":[0.9979334,0.001124795,0.0001549653,0.0002342337,0.0004428215,0.0001098032],"domain_scores_gemma":[0.9968883,0.0008955349,0.001474432,0.0002220239,0.0002650323,0.000254712],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1229743,0.00256229,0.7722026,0.0008324978,0.008646002,0.0001761732,0.0002411082,0.002210442,0.01451207,0.00007354253,0.0005599206,0.07500912],"study_design_scores_gemma":[0.01378415,0.06731129,0.9018492,0.00007997258,0.005173713,0.0009349301,0.0001497228,0.002432366,0.005429294,0.00007619285,0.00274696,0.00003213768],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971012,0.001805258,0.0002155493,0.00003006303,0.000003630849,0.00007517159,0.0004182737,0.000007188095,0.0003436416],"genre_scores_gemma":[0.9979689,0.0003860727,0.0002634026,0.00005930563,0.00001488666,0.0000400455,0.001124153,0.000002520796,0.0001407219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004956257,"threshold_uncertainty_score":0.0262115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2625362849","doi":"10.1038/s41467-017-00393-y","title":"Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer","year":2017,"lang":"en","type":"article","venue":"Nature Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Vetenskapsrådet; Cancerfonden; National Institute for Health and Care Research; Academy of Medical Sciences; Cancer Research UK; NIHR Cambridge Biomedical Research Centre; Pain Relief Foundation; AFA Försäkring; Hutchison Whampoa Limited; Wellcome Trust; AstraZeneca; National Cancer Research Institute; Torsten Söderbergs Stiftelse; Public Health Agency; Cancer Research Institute","keywords":"Prostate cancer; Androgen receptor; Androgen deprivation therapy; Synthetic lethality; Cancer research; PARP inhibitor; Poly ADP ribose polymerase; Downregulation and upregulation; Prostate; Medicine; Cancer; Biology; Internal medicine; DNA repair; Genetics; Gene","authors":[{"name":"Mohammad Asim","is_ca":false},{"name":"Firas Tarish","is_ca":false},{"name":"Heather Zecchini","is_ca":false},{"name":"Kumar Sanjiv","is_ca":false},{"name":"Eleni Gelali","is_ca":false},{"name":"Charles Massie","is_ca":false},{"name":"Ajoeb Baridi","is_ca":false},{"name":"Anne Y. Warren","is_ca":false},{"name":"Wanfeng Zhao","is_ca":false},{"name":"Christoph Ogris","is_ca":false},{"name":"Leigh‐Anne McDuffus","is_ca":false},{"name":"Patrice Mascalchi","is_ca":false},{"name":"Greg Shaw","is_ca":false},{"name":"Harveer Dev","is_ca":false},{"name":"Karan Wadhwa","is_ca":false},{"name":"Paul W.G. Wijnhoven","is_ca":false},{"name":"Josep V. Forment","is_ca":false},{"name":"Andy G. Lynch","is_ca":false},{"name":"Cormac O’Neill","is_ca":false},{"name":"Vincent Zecchini","is_ca":false},{"name":"Paul S. Rennie","is_ca":true},{"name":"Aria Baniahmad","is_ca":false},{"name":"Simon Tavaré","is_ca":false},{"name":"Ian G. Mills","is_ca":false},{"name":"Yaron Galanty","is_ca":false},{"name":"Nicola Crosetto","is_ca":false},{"name":"Niklas Schultz","is_ca":false},{"name":"David E. Neal","is_ca":false},{"name":"Thomas Helleday","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0531525519722865,"gpt":0.3711102333803341,"spread":0.3179576814080475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002731755,0.0003177816,0.0002697043,0.0002969557,0.0001341565,0.0003759289,0.0002199985,0.0002786007,0.001519766],"category_scores_gemma":[0.0001316295,0.0001523437,0.0002296166,0.0001699469,0.0002226396,0.0001794913,0.0002815878,0.0006057763,0.0003191254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002182213,"about_ca_system_score_gemma":0.0002599452,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001959863,"about_ca_topic_score_gemma":0.0002752802,"domain_scores_codex":[0.9997851,0.00006088792,0.0000198298,0.00002674108,0.00007787365,0.00002964516],"domain_scores_gemma":[0.9998264,0.00005440638,0.00004411118,0.00002551864,0.000009926554,0.0000397222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003810611,0.00009379449,0.0006510901,0.0001466687,0.00002639212,0.0003274886,0.00001968206,0.0005758393,0.9837261,0.001810177,0.0003599892,0.01188177],"study_design_scores_gemma":[0.00004841485,0.002032347,0.006695746,0.00001478884,0.00003929214,0.003355455,0.0000292183,0.001482521,0.9726097,0.000715845,0.01296238,0.00001421918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9466842,0.0256095,0.01530363,0.00104779,0.0001995453,0.00007750862,0.001038558,0.0005782399,0.009460934],"genre_scores_gemma":[0.9903685,0.004553095,0.001998998,0.0001554693,0.00003009142,0.0000222166,0.0005054639,0.00001822013,0.002348058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001519766,"threshold_uncertainty_score":0.005084157,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2898861270","doi":"10.15252/emmm.201809172","title":"A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation","year":2018,"lang":"en","type":"article","venue":"EMBO Molecular Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Université Laval; Centre hospitalier de l'Université Laval","funders":"Instituto de Salud Carlos III; European Society for Medical Oncology; Canadian HIV Trials Network, Canadian Institutes of Health Research; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; Cancer Research UK; Generalitat de Catalunya; Fundación Científica Asociación Española Contra el Cáncer; Fundación Cellex; AstraZeneca","keywords":"Mutation; Molecular biology; Poly ADP ribose polymerase; Chemistry; Biology; Cancer research; Genetics; DNA; Gene; Polymerase","authors":[{"name":"Marta Castroviejo‐Bermejo","is_ca":false},{"name":"Cristina Cruz","is_ca":false},{"name":"Alba Llop‐Guevara","is_ca":false},{"name":"Sara Gutiérrez‐Enríquez","is_ca":false},{"name":"Mandy Ducy","is_ca":true},{"name":"Yasir H. Ibrahim","is_ca":false},{"name":"Albert Gris‐Oliver","is_ca":false},{"name":"Benedetta Pellegrino","is_ca":false},{"name":"Alejandra Bruna","is_ca":false},{"name":"Marta Guzmán","is_ca":false},{"name":"Olga Rodríguez","is_ca":false},{"name":"Judit Grueso","is_ca":false},{"name":"Sandra Bonache","is_ca":false},{"name":"Alejandro Moles‐Fernández","is_ca":false},{"name":"Guillermo Villacampa","is_ca":false},{"name":"Cristina Viaplana","is_ca":false},{"name":"Patricia Gómez","is_ca":false},{"name":"María Vidal","is_ca":false},{"name":"Vicente Peg","is_ca":false},{"name":"Xavier Serres","is_ca":false},{"name":"Graham Dellaire","is_ca":true},{"name":"Jacques Simard","is_ca":true},{"name":"Paolo Nucíforo","is_ca":false},{"name":"Isabel T. Rubio","is_ca":false},{"name":"Rodrigo Dienstmann","is_ca":false},{"name":"J. Carl Barrett","is_ca":false},{"name":"Carlos Caldas","is_ca":false},{"name":"José Baselga","is_ca":false},{"name":"Cristina Saura","is_ca":false},{"name":"Javier Cortés","is_ca":false},{"name":"Olivier Déas","is_ca":false},{"name":"Jos Jonkers","is_ca":false},{"name":"Jean‐Yves Masson","is_ca":true},{"name":"Stefano Cairo","is_ca":false},{"name":"Jean‐Gabriel Judde","is_ca":false},{"name":"Mark J. O’Connor","is_ca":false},{"name":"Orland Dı́ez","is_ca":false},{"name":"Judith Balmañà","is_ca":false},{"name":"Violeta Serra","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02386045222621364,"gpt":0.3273131591371021,"spread":0.3034527069108885,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001664942,0.0007500816,0.0005743116,0.002277985,0.0002261828,0.0007863955,0.000325713,0.0007730721,0.003778097],"category_scores_gemma":[0.002063031,0.0002979357,0.0003718488,0.001115469,0.0003997878,0.000352227,0.0003082508,0.0007092904,0.001846255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002432539,"about_ca_system_score_gemma":0.0001660505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003564516,"about_ca_topic_score_gemma":0.0007439474,"domain_scores_codex":[0.9987876,0.0003456426,0.0001538214,0.0003602765,0.0002677141,0.00008501777],"domain_scores_gemma":[0.9984257,0.0006313355,0.0003452983,0.00022917,0.0002733301,0.00009521257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001480438,0.0001928152,0.2515239,0.0003368988,0.0001770346,0.0004149942,0.0001370804,0.0006201554,0.6989443,0.0004604472,0.001447457,0.04426447],"study_design_scores_gemma":[0.0000403021,0.001253089,0.4993733,0.00005713915,0.000209796,0.003268855,0.0001469295,0.004722523,0.4818901,0.0005392223,0.008459321,0.00003932742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9421991,0.007601177,0.03323333,0.000352354,0.0002169778,0.0002610874,0.003829526,0.001145614,0.01116078],"genre_scores_gemma":[0.9655902,0.001839123,0.02568135,0.0002503645,0.00005745985,0.0001567523,0.002978597,0.00009707523,0.003349068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003778097,"threshold_uncertainty_score":0.01263899,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2608211931","doi":"10.1158/2159-8290.cd-17-0146","title":"Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of <i>BRCA2</i> Reversion Mutations Associated with Resistance to PARP Inhibitors","year":2017,"lang":"en","type":"article","venue":"Cancer Discovery","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Cancer Research UK","keywords":"Reversion; DNA; Mutation; Poly ADP ribose polymerase; DNA damage; Biology; Chemistry; Cancer research; Genetics; Gene; Phenotype","authors":[{"name":"David A. Quigley","is_ca":false},{"name":"Joshi J. Alumkal","is_ca":false},{"name":"Alexander W. Wyatt","is_ca":true},{"name":"Vishal Kothari","is_ca":false},{"name":"Adam Foye","is_ca":false},{"name":"Paul Lloyd","is_ca":false},{"name":"Rahul Aggarwal","is_ca":false},{"name":"Won Bae Kim","is_ca":false},{"name":"Eric Lu","is_ca":false},{"name":"Jacob Schwartzman","is_ca":false},{"name":"Kevin Beja","is_ca":true},{"name":"Matti Annala","is_ca":true},{"name":"Rajdeep Das","is_ca":false},{"name":"Morgan E. Diolaiti","is_ca":false},{"name":"Colin C. Pritchard","is_ca":false},{"name":"George Thomas","is_ca":false},{"name":"Scott A. Tomlins","is_ca":false},{"name":"Karen E. Knudsen","is_ca":false},{"name":"Christopher J. Lord","is_ca":false},{"name":"Charles J. Ryan","is_ca":false},{"name":"Jack Youngren","is_ca":false},{"name":"Tomasz M. Beer","is_ca":false},{"name":"Alan Ashworth","is_ca":false},{"name":"Eric J. Small","is_ca":false},{"name":"Felix Y. Feng","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02755752012958285,"gpt":0.3162239602348135,"spread":0.2886664401052306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002073002,0.0001902582,0.0001704393,0.0007509374,0.0001445282,0.0003955876,0.0002145442,0.0005852939,0.002224048],"category_scores_gemma":[0.0005538867,0.0001298727,0.0001107723,0.0002618169,0.0002934705,0.000168728,0.0002317043,0.0004706918,0.0005217741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003118389,"about_ca_system_score_gemma":0.0001187004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007115426,"about_ca_topic_score_gemma":0.0009866195,"domain_scores_codex":[0.9998053,0.00002431274,0.00001501248,0.00007249262,0.00005330209,0.00002959962],"domain_scores_gemma":[0.999602,0.0001382356,0.00009119672,0.00004383113,0.00006765289,0.00005704774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0005378469,0.00004839263,0.03600156,0.0001060014,0.00004230624,0.00124654,0.0001327707,0.0001666757,0.9269184,0.0002693236,0.00172205,0.03280809],"study_design_scores_gemma":[0.0001352733,0.001122414,0.2773281,0.00009141658,0.000133447,0.02993703,0.0002978479,0.003658442,0.6623254,0.001330306,0.02359164,0.00004877983],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9711096,0.007163879,0.01291959,0.001601017,0.0001989758,0.00009358353,0.00205039,0.0004688108,0.004394098],"genre_scores_gemma":[0.9917374,0.001102391,0.00400035,0.0006091278,0.0000690016,0.00003424777,0.000793167,0.00004752439,0.001606685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002224048,"threshold_uncertainty_score":0.007440209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2151209400","doi":"10.1073/pnas.1108799108","title":"Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage","year":2011,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; National Institutes of Health; National Institute on Drug Abuse; McKnight Foundation","keywords":"Ubiquitin ligase; DNA ligase; Molecular biology; DDB1; DNA repair; Ubiquitin; Biology; Ku70; DNA damage; Cell biology; Biochemistry; Chemistry; DNA","authors":[{"name":"Ho Chul Kang","is_ca":false},{"name":"Yun-Il Lee","is_ca":false},{"name":"Joo‐Ho Shin","is_ca":false},{"name":"Shaida A. Andrabi","is_ca":false},{"name":"Zhikai Chi","is_ca":false},{"name":"Jean-Philippe Gagné","is_ca":false},{"name":"Yunjong Lee","is_ca":false},{"name":"Han Seok Ko","is_ca":false},{"name":"Byoung Dae Lee","is_ca":false},{"name":"Guy G. Poirier","is_ca":false},{"name":"Valina L. Dawson","is_ca":true},{"name":"Ted M. Dawson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1049182062704579,"gpt":0.3338820552357509,"spread":0.228963848965293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009061358,0.0005000593,0.0004284026,0.0003344013,0.0003511399,0.0006213789,0.0003293646,0.0003172489,0.001004815],"category_scores_gemma":[0.00007303115,0.0001758633,0.0004607442,0.0002734154,0.0002276273,0.0002675741,0.0003308462,0.0003723639,0.0008926908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005745698,"about_ca_system_score_gemma":0.0002200599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005293089,"about_ca_topic_score_gemma":0.0005944395,"domain_scores_codex":[0.9998856,0.000007047504,0.000008407349,0.00003851807,0.00003475327,0.00002559293],"domain_scores_gemma":[0.9999249,0.000004385334,0.00002470174,0.000009045079,0.00001111459,0.00002594403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001866619,0.00004689519,0.003903963,0.0001406973,0.00003843305,0.0002747694,0.00002012192,0.0002738067,0.9816228,0.00055262,0.0004961982,0.01244312],"study_design_scores_gemma":[0.00001312241,0.0001792508,0.01336233,0.000009306395,0.00004727638,0.00192259,0.00003795436,0.001381703,0.9510348,0.0001743943,0.03182117,0.00001610674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9087256,0.02289104,0.05234186,0.0003383855,0.0002065603,0.0001204052,0.002998877,0.00125205,0.01112521],"genre_scores_gemma":[0.9652756,0.006209538,0.01296807,0.0001903731,0.0000254434,0.00003033208,0.004835732,0.00004030983,0.01042447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001004815,"threshold_uncertainty_score":0.004168868,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142194813","doi":"10.1016/j.cell.2011.10.046","title":"Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease","year":2011,"lang":"en","type":"article","venue":"Cell","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Canada Research Chairs; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"National Center for Research Resources; Canadian Institutes of Health Research; Terry Fox Foundation; Human Frontier Science Program; National Institutes of Health; European Molecular Biology Organization; U.S. Department of Energy","keywords":"Ankyrin repeat; Cherubism; Biology; Peptide sequence; Genetics; Ankyrin; Computational biology; Polymerase; Biochemistry; DNA; Gene","authors":[{"name":"Sebastian Guettler","is_ca":true},{"name":"José LaRose","is_ca":true},{"name":"Evangelia Petsalaki","is_ca":true},{"name":"Gerald Gish","is_ca":true},{"name":"Andy Scotter","is_ca":true},{"name":"Tony Pawson","is_ca":true},{"name":"Robert Rottapel","is_ca":true},{"name":"Frank Sicheri","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1007135040464307,"gpt":0.2988541061465599,"spread":0.1981406021001292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004478784,0.000472342,0.0006930715,0.0003063871,0.0007546199,0.001014633,0.0009968014,0.001243926,0.002959923],"category_scores_gemma":[0.0006838483,0.0002669083,0.0006650868,0.0001883891,0.0009529106,0.001542151,0.0004939017,0.002112062,0.001854913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006384678,"about_ca_system_score_gemma":0.0004542603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00029869,"about_ca_topic_score_gemma":0.0002688922,"domain_scores_codex":[0.9998504,0.00001940105,0.00001347371,0.00004217637,0.00003757112,0.00003693471],"domain_scores_gemma":[0.9998221,0.00005216902,0.00003716555,0.0000375869,0.00002646295,0.00002451141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007229131,0.0001445536,0.002575709,0.0002966191,0.00008032923,0.003021962,0.0002936245,0.01431409,0.7995154,0.1569111,0.003637803,0.01848577],"study_design_scores_gemma":[0.0002841108,0.0007134655,0.003289848,0.00006323339,0.0001387127,0.00588759,0.0004040707,0.07559296,0.6629199,0.2105457,0.04000117,0.0001592507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7957592,0.005735249,0.169934,0.008005018,0.000995842,0.0001426159,0.0008108878,0.001229473,0.0173877],"genre_scores_gemma":[0.9784025,0.001442197,0.01627849,0.0006239364,0.0000928923,0.00004647697,0.0003677214,0.00008409216,0.002661731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002959923,"threshold_uncertainty_score":0.009902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2270704840","doi":"10.1038/nm.4032","title":"Blocking c-Met–mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors","year":2016,"lang":"en","type":"article","venue":"Nature Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"PARP1; Olaparib; Poly ADP ribose polymerase; Cancer research; PARP inhibitor; Synthetic lethality; DNA damage; Cancer cell; Cancer; DNA repair; Biology; Medicine; Polymerase; Enzyme; Internal medicine; DNA; Biochemistry","authors":[{"name":"Yi Du","is_ca":false},{"name":"Hirohito Yamaguchi","is_ca":false},{"name":"Yongkun Wei","is_ca":false},{"name":"Jennifer L. Hsu","is_ca":false},{"name":"Hung-Ling Wang","is_ca":false},{"name":"Yi‐Hsin Elsa Hsu","is_ca":false},{"name":"Wan-Chi Lin","is_ca":false},{"name":"Wen-Hsuan Yu","is_ca":false},{"name":"Paul G. Leonard","is_ca":false},{"name":"Gilbert R. Lee","is_ca":false},{"name":"Mei‐Kuang Chen","is_ca":false},{"name":"Katsuya Nakai","is_ca":false},{"name":"Ming‐Chuan Hsu","is_ca":false},{"name":"Chun‐Te Chen","is_ca":false},{"name":"Ye Sun","is_ca":false},{"name":"Yun Wu","is_ca":false},{"name":"Wei-Chao Chang","is_ca":false},{"name":"Wen-Chien Huang","is_ca":false},{"name":"Chien‐Liang Liu","is_ca":false},{"name":"Yuan-Ching Chang","is_ca":false},{"name":"Chung‐Hsuan Chen","is_ca":false},{"name":"Morag Park","is_ca":true},{"name":"Philip Jones","is_ca":false},{"name":"Gabriel N. Hortobágyi","is_ca":false},{"name":"Mien‐Chie Hung","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005994849007095061,"gpt":0.2822921896554457,"spread":0.2762973406483506,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002209305,0.0003734225,0.000371996,0.0002276388,0.0002040103,0.0003153681,0.0003273317,0.0003145279,0.004964044],"category_scores_gemma":[0.0002273679,0.0001829281,0.0002740622,0.0002150823,0.0001889314,0.0003359118,0.0001562232,0.001373094,0.0006720652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000257089,"about_ca_system_score_gemma":0.0003025895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004453182,"about_ca_topic_score_gemma":0.001170536,"domain_scores_codex":[0.9997851,0.00004356592,0.00001812348,0.00002463454,0.00004881367,0.00007972615],"domain_scores_gemma":[0.9998949,0.00002977757,0.00002384467,0.00001333777,0.000009964425,0.00002811001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002989765,0.0008709849,0.000360673,0.000194724,0.00005822186,0.00009768261,0.00002584037,0.0007521478,0.9697469,0.0004386891,0.001284372,0.02317989],"study_design_scores_gemma":[0.0002064353,0.003591943,0.004725578,0.00001097897,0.00004260333,0.0003796394,0.00002612678,0.001708782,0.9838316,0.0001097814,0.005355964,0.00001053551],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843646,0.004748933,0.002971446,0.0004661056,0.0001971352,0.00006648231,0.0005924597,0.0002199544,0.006372896],"genre_scores_gemma":[0.9934245,0.001813423,0.001431374,0.00008120792,0.00003803105,0.00002900571,0.0005809192,0.00001479486,0.002586795],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004964044,"threshold_uncertainty_score":0.01660639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2124470568","doi":"10.1158/0008-5472.can-10-2352","title":"Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment","year":2010,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Cancer Research UK; Abbott Laboratories","keywords":"PARP inhibitor; PARP1; Poly ADP ribose polymerase; Clonogenic assay; Cancer research; RAD51; Synthetic lethality; Biology; Cancer cell; DNA damage; DNA repair; In vivo; Molecular biology; Cancer; Polymerase; DNA; Genetics","authors":[{"name":"Norman Chan","is_ca":true},{"name":"Isabel M. Pires","is_ca":true},{"name":"Zuzana Bencokova","is_ca":true},{"name":"Carla Coackley","is_ca":true},{"name":"Kaisa R. Luoto","is_ca":true},{"name":"Nirmal Bhogal","is_ca":true},{"name":"Minalini Lakshman","is_ca":true},{"name":"Ponnari Gottipati","is_ca":true},{"name":"F. Javier Oliver","is_ca":true},{"name":"Thomas Helleday","is_ca":true},{"name":"Ester M. Hammond","is_ca":true},{"name":"Robert G. Bristow","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07678439385390248,"gpt":0.4114094948835611,"spread":0.3346251010296586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001219057,0.0003742212,0.0002370431,0.000108091,0.00008276807,0.0002053017,0.0001987574,0.000204873,0.001313854],"category_scores_gemma":[0.00008120952,0.0001143186,0.0001898566,0.00006287295,0.0001973466,0.0001501135,0.0002691749,0.0003472362,0.0001493826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001671361,"about_ca_system_score_gemma":0.00009354202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001544691,"about_ca_topic_score_gemma":0.0003095929,"domain_scores_codex":[0.9998443,0.00002986815,0.00001117917,0.00003809462,0.00004535417,0.00003103102],"domain_scores_gemma":[0.999882,0.00002281179,0.00004781321,0.00002150037,0.000008408177,0.00001744674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001050273,0.00001801107,0.0002831931,0.00003023923,0.000008784076,0.00004675728,0.00000717781,0.000144166,0.9982417,0.0001093359,0.00003372677,0.0009718368],"study_design_scores_gemma":[0.000005070969,0.000495749,0.003689088,0.00000380542,0.0000137046,0.0004002323,0.000009168637,0.0005652928,0.9937444,0.00002758986,0.001042504,0.000003333371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879003,0.00185425,0.008037187,0.00005423363,0.00002771473,0.00005404075,0.0004459606,0.0001452672,0.001481209],"genre_scores_gemma":[0.9967001,0.0005433694,0.001615623,0.00003524441,0.000006934672,0.0000312064,0.0003745435,0.00001645113,0.0006765696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001313854,"threshold_uncertainty_score":0.004395306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2593067736","doi":"10.1158/1078-0432.ccr-16-2796","title":"A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Germline; Medicine; Cancer research; Germline mutation; Ovarian carcinoma; Internal medicine; Oncology; Cancer; Mutation; Poly ADP ribose polymerase; Biology; Genetics; DNA; Polymerase","authors":[{"name":"Rebecca Kristeleit","is_ca":false},{"name":"Geoffrey I. Shapiro","is_ca":false},{"name":"Howard A. Burris","is_ca":false},{"name":"Amit M. Oza","is_ca":true},{"name":"Patricia LoRusso","is_ca":false},{"name":"Manish R. Patel","is_ca":false},{"name":"Susan M. Domchek","is_ca":false},{"name":"Judith Balmañà","is_ca":false},{"name":"Yvette Drew","is_ca":false},{"name":"Lee-may Chen","is_ca":false},{"name":"Tamar Safra","is_ca":false},{"name":"Ana Fernández Montés","is_ca":false},{"name":"Heidi Giordano","is_ca":false},{"name":"Lara Maloney","is_ca":false},{"name":"Sandra Goble","is_ca":false},{"name":"Jeff Isaacson","is_ca":false},{"name":"Jim Xiao","is_ca":false},{"name":"Jen Borrow","is_ca":false},{"name":"Lindsey Rolfe","is_ca":false},{"name":"Ronnie Shapira‐Frommer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2419675665224092,"gpt":0.5440788431986607,"spread":0.3021112766762516,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001464121,0.001326898,0.002243269,0.0003558825,0.000504827,0.0008440273,0.0006220864,0.0009321487,0.002964942],"category_scores_gemma":[0.00102908,0.0007684127,0.001049567,0.0004310411,0.0008151772,0.0007181119,0.000316621,0.00295507,0.0007189531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008150145,"about_ca_system_score_gemma":0.00176558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000878704,"about_ca_topic_score_gemma":0.001875989,"domain_scores_codex":[0.9995079,0.0002365407,0.00002710896,0.00009908248,0.0000494862,0.00007989202],"domain_scores_gemma":[0.9992292,0.0001345436,0.0001147866,0.00007118675,0.00004955211,0.000400755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6594992,0.1380446,0.01826742,0.0009747061,0.001637027,0.0005732978,0.0004343642,0.002706826,0.05072147,0.0003000735,0.004889319,0.1219518],"study_design_scores_gemma":[0.5084277,0.4673535,0.01723473,0.00002601878,0.000393567,0.0003422528,0.00005435217,0.001049527,0.002405744,0.0001370486,0.002548712,0.00002675028],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930841,0.001589839,0.0005235683,0.000314882,0.0000910933,0.002390728,0.000553621,0.00005169001,0.00140066],"genre_scores_gemma":[0.9912345,0.00135731,0.001522859,0.0007761379,0.0001964148,0.001994357,0.001527395,0.00002169388,0.001369279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002964942,"threshold_uncertainty_score":0.009918749,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}